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A B S T R A C T
Background
Non-invasive physical treatments are often used to treat common types of chronic/recurrent headache.
Objectives
To quantify and compare the magnitude of short- and long-term effects of non-invasive physical treatments for chronic/recurrent
headaches.
Search strategy
We searched the following databases from their inception to November 2002: MEDLINE, EMBASE, BIOSIS, CINAHL, Science
Citation Index, Dissertation Abstracts, CENTRAL, and the Specialised Register of the Cochrane Pain, Palliative Care and Supportive
Care review group. Selected complementary medicine reference systems were searched as well. We also performed citation tracking and
hand searching of potentially relevant journals.
Selection criteria
We included randomized and quasi-randomized controlled trials comparing non-invasive physical treatments for chronic/recurrent
headaches to any type of control.
Data collection and analysis
Two independent reviewers abstracted trial information and scored trials for methodological quality. Outcomes data were standardized
into percentage point and effect size scores wherever possible. The strength of the evidence of effectiveness was assessed using pre-
specified rules.
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Main results
Twenty-two studies with a total of 2628 patients (age 12 to 78 years) met the inclusion criteria. Five types of headache were studied:
migraine, tension-type, cervicogenic, a mix of migraine and tension-type, and post-traumatic headache. Ten studies had methodological
quality scores of 50 or more (out of a possible 100 points), but many limitations were identified. We were unable to pool data because
of study heterogeneity.
For the prophylactic treatment of migraine headache, there is evidence that spinal manipulation may be an effective treatment option
with a short-term effect similar to that of a commonly used, effective drug (amitriptyline). Other possible treatment options with
weaker evidence of effectiveness are pulsating electromagnetic fields and a combination of transcutaneous electrical nerve stimulation
[TENS] and electrical neurotransmitter modulation.
For the prophylactic treatment of chronic tension-type headache, amitriptyline is more effective than spinal manipulation during
treatment. However, spinal manipulation is superior in the short term after cessation of both treatments. Other possible treatment
options with weaker evidence of effectiveness are therapeutic touch; cranial electrotherapy; a combination of TENS and electrical
neurotransmitter modulation; and a regimen of auto-massage, TENS, and stretching. For episodic tension-type headache, there is
evidence that adding spinal manipulation to massage is not effective.
For the prophylactic treatment of cervicogenic headache, there is evidence that both neck exercise (low-intensity endurance training)
and spinal manipulation are effective in the short and long term when compared to no treatment. There is also evidence that spinal
manipulation is effective in the short term when compared to massage or placebo spinal manipulation, and weaker evidence when
compared to spinal mobilization.
There is weaker evidence that spinal mobilization is more effective in the short term than cold packs in the treatment of post-traumatic
headache.
Authors’ conclusions
A few non-invasive physical treatments may be effective as prophylactic treatments for chronic/recurrent headaches. Based on trial
results, these treatments appear to be associated with little risk of serious adverse effects. The clinical effectiveness and cost-effectiveness
of non-invasive physical treatments require further research using scientifically rigorous methods. The heterogeneity of the studies
included in this review means that the results of a few additional high-quality trials in the future could easily change the conclusions
of our review.
P L A I N L A N G U A G E S U M M A R Y
Non-invasive physical treatments for chronic/recurrent headaches
Various physical treatments are often used instead of, or in addition to, medications to treat headaches. Evidence from controlled
trials suggests that several non-invasive physical treatments may help prevent chronic/recurrent headaches. Spinal manipulation may be
effective for migraine and chronic tension-type headache. Both spinal manipulation and neck exercises may be effective for cervicogenic
headache. Weaker evidence suggests that other treatments may also be effective: pulsating electromagnetic fields and transcutaneous
electrical nerve stimulation (TENS) for migraine, and therapeutic touch, cranial electrotherapy, TENS, and a combination of self-
massage/TENS/stretching for tension-type headache. Although none of these treatments has conclusive evidence for effectiveness, all
appear to be associated with little risk of serious adverse effects.
B A C K G R O U N D
Headache is an extremely common complaint in the industrialized
world, with a 1-day prevalence in the general population of approx-
imately 16% (Rasmussen 1991). Migraine affects 10% to 12%
of the population annually (Stewart 1992), while tension-type
headache affects over 38% (Schwartz 1998). Although headache
is normally a benign disorder and most cases are moderate or mild,
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the human and socioeconomic impact is considerable due to lost
work days and days with reduced work efficiency (Pryse-Phillips
1992; Schwartz 1998). The financial cost of headaches is huge. It
is estimated that 57% of headache-related lost work days in the US
are attributable to migraines, while 43% are due to tension-type
and other headaches (Schwartz 1997). Migraine alone costs Amer-
ican employers about US$13 billion per year because of missed
workdays and impaired work function (Hu 1999).
There are several headache treatment approaches. Often,
headaches are treated pharmacologically, but many patients also
receive various forms of physical treatment (Eisenberg 1998;
Rasmussen 1992). Physical treatments include massage, trigger
point therapy, reflexology, spinal manipulation, therapeutic heat
or cold, and exercise therapy, among others. Several systematic re-
views have assessed the effectiveness of different forms of physical
treatments for chronic/recurrent headache (Bronfort 2001; Gross
2002; Holroyd 1990; Hurwitz 1996; Klawansky 1995; McCrory
2001; Melchart 2001; Vernon 1999). These reviews address dif-
ferent types of therapies and headaches and, consequently, come to
somewhat different conclusions. This makes it difficult for health-
care providers to make up-to-date evidence-based decisions regard-
ing which physical treatments to consider. This Cochrane review
updates one of the above-mentioned systematic reviews (Bronfort
2001) and represents the most comprehensive evaluation to date
of the evidence regarding the efficacy of physical treatments for all
types of headaches.
O B J E C T I V E S
The objectives of the review were to quantify and compare the
magnitude of short- and long-term effects of specific non-invasive
physical treatments for chronic/recurrent headaches classified ac-
cording to the International Headache Society (IHS) diagnostic
criteria (IHS 1988). The levels of evidence in support of these
treatments were determined based on pre-specified rules.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomized controlled trials (RCTs) and quasi-ran-
domized studies (e.g., allocation by date of birth, hospital record
number, or alternation). RCTs and quasi-randomized studies were
analyzed separately. Study reports could be in any language.
Types of participants
We included persons of any age with chronic/recurrent headaches
including, but not limited to, episodic and chronic tension-type
headache, cluster headache, cervicogenic headache, and migraine,
classified according to the IHS criteria (IHS 1988). Some studies
were anticipated to pre-date or not adhere to the 1988 IHS clas-
sification system.
Types of interventions
Included studies had to assess the effect of one or more types of
non-invasive physical treatments. These included, but were not
limited to, therapeutic heat or cold; traction; electrical modali-
ties, such as transcutaneous electrical nerve stimulation (TENS),
interferential therapy, electromagnetic therapy, microcurrent, ul-
trasound, and laser; exercise; spinal manipulation or mobiliza-
tion; massage; reflexology; stretching; and trigger-point therapy.
Acupuncture and psychological interventions such as biofeedback
and relaxation were excluded. A separate Cochrane review has been
devoted to acupuncture (Melchart 2001), and psychological inter-
ventions will be addressed in future reviews (see, e.g., Nicholson
2004). These treatments were, however, included as comparison
therapies in studies that also featured non-invasive physical treat-
ments. In general, acceptable comparator groups included placebo,
no treatment (e.g., wait-list control), and any other type of active
intervention.
Types of outcome measures
The trials must have reported on at least one patient-rated out-
come measure such as headache pain intensity, headache index,
frequency, duration, improvement, analgesic use, activities of daily
living, quality of life, functional health status, or patient satisfac-
tion. Data on costs and side effects of treatment, if available, were
reported in the review.
Search methods for identification of studies
We identified studies by a comprehensive computerized search of
MEDLINE (January 1966 to November 2002), EMBASE (Jan-
uary 1974 to November 2002), BIOSIS (January 1996 to Novem-
ber 2002), CINAHL (January 1980 to November 2002), Sci-
ence Citation Index (January 1974 to December 1990), Disser-
tation Abstracts (July 1980 to November 2002), the Cochrane
Central Register of Controlled Trials (CENTRAL; Issue 3, 2002),
and the Specialised Register of the Cochrane Pain, Palliative Care
and Supportive Care Collaborative Review Group (2002). Addi-
tionally, studies were identified through complementary medicine
reference systems such as Chirolars/MANTIS (March 1992 to
November 2002), the Index to Chiropractic Literature (ICL; Jan-
uary 1985 to November 2002), and the Chiropractic Research
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Archives/Abstracts Collection (CRAC; January 1984 to Decem-
ber 1990). Finally, we performed citation tracking; hand searched
non-indexed physical therapy, chiropractic, osteopathic, and man-
ual medicine journals; hand searched non-indexed dissertations;
and examined references found in relevant publications.
In MEDLINE, a published search strategy for identifying RCTs
(Dickersin 1994) was applied in combination with specific search
terms, without language restriction. The full MEDLINE search
strategy, which was adapted for use in the other electronic
databases, is provided in Appendix 1.
Data collection and analysis
Study identification
The two main reviewers (GB and NN) independently selected
trials to be included in the review based on the explicit search
strategy. The reviewers were too familiar with the relevant RCTs
to conduct blinded reviews. Differences in the results of selection
were resolved by discussion between the two reviewers; a third
reviewer (WJJA or LMB) was consulted if disagreements could
not be resolved. Articles were initially selected on the basis of
the abstracts; if a determination could not be made based on the
abstracts, the full articles were retrieved.
Data extraction
Explicit information about patient demographics, type of
headache, clinical characteristics, interventions, and outcome
measures were recorded using standardized abstracting forms. Two
non-blinded reviewers (NN and GB) independently extracted and
recorded relevant data from each article. All original data on out-
comes were standardized into percentage point and effect size (ES)
scores whenever possible. Efforts were made to contact authors if
there was uncertainty about important aspects of methods or data
in the published report.
Categorization of short- and long-term outcomes
Short-term follow up was defined as outcomes evaluated up to 3
months after the initial study treatment. Long-term follow up was
defined as outcomes evaluated more than 3 months after onset of
study therapy.
Assessment of methodological quality
The methodological scoring of the trials was performed by two
reviewers independently (NN and GB). In addition to the short
methodological quality checklist developed by Jadad et al (Jadad
1996), we used a critical evaluation list of 20 methodological items
and their operational definitions to assess methodological quality.
This list (see below for the operational definitions used) represents
a modification of previously used instruments (Assendelft 1996a;
Koes 1991). Fourteen of the items were used to compute a valid-
ity score, and six related to descriptive information. The validity
items included assessment of study group comparability at base-
line, adequacy of randomization process, reliability and validity of
outcome measures, blinding of patients and treatment providers,
bias in measurement of outcomes, attention bias, definition of
tested hypothesis, impact of dropouts and missing data, intention-
to-treat analysis, and adjustments for number of statistical tests
used. Differences in scores were resolved by discussion between
the two reviewers (NN and GB); a third reviewer was consulted if
disagreements could not be resolved.
The critical evaluation list contains 20 methodological items (A-
T), of which 14 (B-G, J, L-N, P-S) have been classified as internal
validity (V) items and six (A, H, I, K, O, and T) as informativeness
(I) items. The following is a description of each item in the list,
accompanied by operational definitions, where needed.
Scoring: A ’YES’ score (+) is used only when all described individ-
ual item criteria are met. ’NO’ (-) is used only when it is clear from
the article that none of the described individual item criteria are
met. ’UNCLEAR/PARTLY’ (p) is used when the documentation
or description is insufficient to answer ’YES’ or ’NO’ as to whether
any or all of the described individual item criteria are met. If an
item did not apply, it was scored ’NOT APPLICABLE’ (na). The
validity score (VS) was derived by dividing 100 by the number of
applicable validity items (maximum of 14).
A. Are the inclusion and exclusion criteria clearly defined? (I-item)
YES: Inclusion and exclusion criteria are stated explicitly.
UNCLEAR/PARTLY: Inclusion and/or exclusion criteria are not
clearly defined.
NO: Inclusion/exclusion criteria are not described.
B. Is it established that the groups are comparable at baseline, or if
different, are appropriate adjustments made during the statistical
analysis? (V-item)
YES: Comparability is established by tabulating important pre-
dictor variables, including baseline value of main outcome, demo-
graphic variables, duration and severity of condition, and other
known prognostic indicators such as patient expectations. If com-
parability is not established, then analysis of co-variance or equiv-
alent is used.
UNCLEAR/PARTLY: Baseline comparability is established for
some, but not all, of the important predictor variables.
NO: Baseline comparability is not established and appropriate
statistical adjustments are not made.
C. Is the randomization procedure adequately described and ap-
propriate? (V-item)
YES: The randomization process is described (e.g., randomly gen-
erated list, opaque envelopes), the method used (simple, block,
stratification, minimization, etc.) is appropriate, and allocation
concealment is established explicitly.
UNCLEAR/PARTLY: One or two of the aforementioned three
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criteria are met.
NO: Information given indicates that randomization was used,
but none of the aforementioned three criteria are met.
D. Is it established that at least one main outcome measure was
relevant to the condition under study, and were adequate reliability
and validity established? (V-item)
YES: At least one of the primary outcomes is patient-oriented
(e.g., pain, functional disability), and its reliability and validity
documented or generally accepted.
UNCLEAR/PARTLY: Documentation of reliability or validity are
absent for an outcome measure that is not generally accepted.
NO: Neither relevance, reliability, nor validity is established.
E. Are patients blinded to the degree possible, and did the blinding
procedure work? (V-item)
YES: Optimal blinding is used and effectiveness of the blinding
procedure is documented.
UNCLEAR/PARTLY: Either optimal blinding or effectiveness of
blinding is not documented.
NO: Neither optimal blinding nor its effectiveness is documented.
NOT APPLICABLE: Trial may not be blindable (e.g., a compar-
ison of a drug and a physical treatment).
F. Is it established that treatment providers were blinded to the
degree possible, and did the blinding procedure work? (V-item)
YES: Optimal blinding is used and effectiveness of the blinding
procedure is documented.
UNCLEAR/PARTLY: Either optimal blinding or effectiveness of
blinding is not documented.
NO: Neither optimal blinding or effectiveness of blinding is doc-
umented.
NOT APPLICABLE: Trial may not be blindable (e.g., a compar-
ison of a drug and a physical treatment).
G. Is it established that assessment of the primary outcomes was
unbiased? (V-item)
YES: Subjects were not influenced by study personnel. It is estab-
lished that assessors were blinded, when relevant.
UNCLEAR/PARTLY: Unclear or no documentation of unbiased
assessment of outcomes.
NO: It is established or highly likely that patients were influenced
by providers or investigators on how they scored their own out-
comes, or it is not established that an assessor was blinded when
applicable.
H. Is the post-intervention follow-up period adequate and consis-
tent with the nature of the condition under study? (I-item)
YES: Minimal acceptable post-intervention follow-up period for
acute conditions is 1 month and for chronic conditions 3 months.
UNCLEAR/PARTLY: A minimum of 2 weeks post-intervention
follow-up period for acute conditions and 1 month for chronic
conditions.
NO: Shorter than 2 weeks post-intervention follow-up period for
acute conditions and 1 month for chronic conditions.
NOT APPLICABLE: May not apply to study (e.g., crossover de-
signs)
I. Are the interventions described adequately? (I-item)
YES: All interventions follow a defined protocol. It is possible from
the description in the article or reference to prescribe or apply the
same treatment in a clinical setting.
UNCLEAR/PARTLY: Unclear or incomplete description of one
or more of the interventions.
NO: Very inadequate or no description of one or more of the
interventions.
J. Were differences in attention bias between groups controlled for
and explicitly described? (V-item)
YES: Documentation that time, provider enthusiasm, and number
of intervention sessions are equivalent among study groups.
UNCLEAR/PARTLY: No documentation that time, provider en-
thusiasm, and number of intervention sessions are equivalent
among study groups.
NO: Evidence that time, provider enthusiasm, and number of in-
tervention sessions are clearly not equivalent among study groups.
NOT APPLICABLE: Pragmatic trials.
K. Is comparison made to existing efficacious or commonly prac-
ticed treatment options? (I-item)
YES: Comparison is made to existing efficacious or commonly
practiced treatment options.
UNCLEAR/PARTLY: Equivocal information.
NO: Comparison is not made to existing efficacious or commonly
practiced treatment options.
NOT APPLICABLE: Placebo-controlled and non-management
trials.
L. Is the primary study objective (hypothesis) clearly defined a
priori in terms of group contrasts, outcomes, and time points? (V-
item)
YES: The primary study objective (hypothesis) is clearly defined
a priori in terms of group contrasts, outcomes, and time points.
UNCLEAR/PARTLY: The primary study objective (hypothesis) is
only partially defined a priori. Information is lacking about either
group contrasts, outcomes, or time points.
NO: The primary study objective (hypothesis) is not defined a
priori in terms of either group contrasts, outcomes, or time points.
M. Is the choice of statistical tests of the main results appropriate?
(V-item)
YES: The main analysis is consistent with the design and the type
of the outcome variables used.
UNCLEAR/PARTLY: The main analysis is not clearly described
or only partially consistent with the design and the type of the
outcome variables used.
NO: The main analysis is clearly inconsistent with the design and/
or the type of the outcome variables used.
N. Is it established at randomization that there is adequate statis-
tical power (1-beta = 0.8, with alpha = 0.05) to detect an a priori
determined clinically important between-group difference of the
primary outcomes, including adjustment for multiple tests and/
or outcome measures? (V-item)
YES: Adequate statistical power documented.
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NO: No documentation of adequate statistical power.
O. Are confidence intervals or data allowing confidence intervals
to be calculated presented? (I-item)
YES: Confidence intervals are presented or can be calculated.
UNCLEAR/PARTLY: Confidence intervals are presented or can
be calculated for only some of the main outcomes.
NO: Confidence intervals are not presented and cannot be calcu-
lated from available data.
P. Are all dropouts described for each study group separately and
accounted for in the analysis of the main outcomes? (V-item)
YES: Analysis of impact of dropouts or worst-/best-case analysis
reported.
UNCLEAR/PARTLY: Incomplete analysis of impact of dropouts.
NO : Analysis of impact of dropouts not performed or reported.
NOT APPLICABLE: Dropout rate less than 5%.
Q. Are all missing data described for each study group separately
and accounted for in the analysis of the main outcomes? (V-item)
YES: Analysis of impact of missing data reported.
UNCLEAR/PARTLY: Incomplete analysis of impact of missing
data.
NO: Analysis of impact of missing data not performed or reported.
NOT APPLICABLE: Missing data less than 5%.
R. If indicated, was intention-to-treat analysis used? (V-item)
YES: All patient data analyzed according to group or initial ran-
dom allocation. In studies with documented full compliance with
allocated treatments and no differential co-intervention between
groups, a YES score can apply.
UNCLEAR/PARTLY: Unclear from article whether intention-to-
treat analysis was used and how.
NO: No intention-to-treat analysis used when applicable.
NOT APPLICABLE: Single-session studies (e.g., studies with one
intervention and outcomes collected in same session).
S. Were adjustments made for the number of statistical tests (two
or more) when establishing a cut-off point for p-level for each test?
(V-item)
YES: Appropriate adjustments made (e.g., Bonferroni’s or similar
type of adjustment).
UNCLEAR/PARTLY: Insufficient adjustment or lack of adequate
information about adjustment.
NO: Adjustments were indicated but not performed.
NOT APPLICABLE: Indicated adjustments were incapable of
changing main result/outcome of study, or study involved only
one test at one time point.
T. Are the main study conclusions valid? (I-item)
YES: A priori testable hypotheses are tested and prioritized appro-
priately in the conclusions.
UNCLEAR/PARTLY: A priori testable hypotheses are only par-
tially tested and/or prioritized appropriately in the conclusions.
NO: A priori testable hypotheses are not tested and prioritized
appropriately in the conclusions.
Quantitative analysis of trial results
Statistical pooling was planned in the case of two or more studies
with comparable interventions, study groups (including headache
type), and outcomes. The pooling methods chosen were fixed or
random effects models as indicated, with effect sizes (ESs) in the
form of weighted mean differences (WMDs) as the effect measure.
It was further planned for the point estimates and 95% confidence
intervals of each trial to be plotted, for statistical homogeneity to
be tested, and for potential sources of variation to be examined in
the case of strong statistical evidence of heterogeneity (p < 0.1).
Effect sizes between the non-invasive physical treatment groups
and the comparison groups were calculated for the end of the
treatment intervention phase and at the main post-treatment fol-
low up. ESs were computed as described by Cohen (Cohen 1988)
and Glass (Glass 1981): difference in treatment and control group
means divided by the pooled standard deviation. In the absence
of these statistics, ESs were calculated from T-scores, and F-val-
ues and confidence intervals, provided sample sizes were given
(Friedman 1968; Glass 1981). ESs for differences in proportions
were estimated using probit transformation (Friedman 1968).
Correction for ES estimate bias associated with small sample sizes
(n < 50) was accomplished using the method described by Hedges
and Olkin (Hedges 1985). If confidence intervals could not be
directly calculated for ESs, they were estimated using p-values and
sample sizes (Hedges 1985).
Outcome scales were normalized to a 100-percentage-point scale.
The percentage point difference was computed as the between-
group mean difference.
Regardless of the degree of statistical heterogeneity, the impact of
specific differences among trials was examined. Subgroup analyses
were planned for (a) trials comparing non-invasive physical treat-
ments with other conservative types of treatment; and (b) trials
comparing different types of non-invasive physical treatments, by
type of headache.
Levels of evidence
The criteria we used to determine the level of evidence of efficacy
were adapted from those developed by the US Agency for Health
Care Policy and Research panel that evaluated the efficacy of vari-
ous treatments for acute low back pain (Bigos 1994). Our system
evaluated the evidence taking into account: (a) type of compari-
son therapy; (b) methodological quality (validity scores); (c) the
number of studies; (d) ES magnitude; and (e) statistical signifi-
cance or ES confidence limits (95% confidence intervals). Table
1 provides detailed definitions of the five levels of evidence and
the terms efficacy, inefficacy, superiority, inferiority, similarity, and
equivalence. The terms ’superior’ and ’inferior’ always indicate ef-
ficacy/inefficacy. Similarity to an efficacious treatment indicates
efficacy. Similarity to a placebo, no treatment, or a component of
a combination therapy indicates inefficacy. No conclusion about
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efficacy can be reached for the case of similarity to a treatment of
currently unknown efficacy.
We defined the five levels of evidence as follows:
• Strong: Two or more high-quality studies (VS = 50 or
higher); evidence of superiority, inferiority, or similarity; and
statistical significance or appropriate confidence limits.
• Moderate: One high-quality study (VS = 50 or higher);
evidence of superiority, inferiority, or similarity; and statistical
significance or appropriate confidence limits.
• Limited: At least one lower-quality study (VS < 50);
evidence of superiority, inferiority, or similarity; and statistical
significance or appropriate confidence limits.
• Preliminary: Study findings did not meet the criteria for
strong, moderate, or limited because of considerations of
statistical significance or confidence limits.
• Conflicting: Findings among studies that could be pooled
were inconsistent.
We recognize the arbitrariness of using a particular magnitude of
ES in the determination of levels of evidence, because there is no
consensus on what constitutes a clinically important difference
between treatment options. We address the ES cutpoint issue in
a sensitivity analysis below. All eligible RCTs were considered re-
gardless of their results.
Statistical pooling of two or more trials was considered if they
were homogeneous in terms of patient population, interventions,
outcomes, and follow-up time points. For determination of the
outcome of each RCT, we considered patient-rated pain intensity
or the headache index as the primary outcome. We considered
frequency, duration, headache improvement, and medication use
the most important secondary outcomes.
R E S U L T S
Description of studies
See: Characteristics of included studies; Characteristics of excluded
studies.
Thirty-six original trials assessing non-invasive physical treatments
were identified by our literature search. Fourteen were excluded
for various reasons (see ’Characteristics of excluded studies’ table).
Twenty-two studies with a total of 2628 patients (age 12 to 78
years) met the inclusion criteria for this review. One was classified
as a quasi-randomized trial (Tuchin 2000); the remaining 21 were
RCTs. The included trials assessed five categories of headache: mi-
graine, tension-type, cervicogenic, mixed migraine and tension-
type, and post-traumatic. It was not possible to map the trials
in the last two categories to any of the International Headache
Society (IHS) diagnoses (IHS 1988). Ten studies used the IHS
criteria for diagnosis and classification (Boline 1995; Bove 1998;
Jull 2002; Marcus 1998; Nelson 1998; Nilsson 1997; Sherman
1998; Sherman 1999; Tuchin 2000; Whittingham 1997). The
non-invasive physical treatments evaluated included spinal ma-
nipulation, mobilization, massage, therapeutic touch, therapeu-
tic exercise, cold packs, and electrical modalities (including pul-
sating electromagnetic fields [PEMF], cranial electrotherapy, in-
terferential therapy, transcutaneous electrical nerve stimulation
[TENS], and ultrasound), and different combinations of physi-
cal treatments. Comparison groups included other non-invasive
treatments, treatments excluded from this review (acupuncture,
rest, relaxation, and biofeedback), medication, placebo, wait-list,
and no-treatment control. The main outcome measures abstracted
from the studies were headache pain intensity, headache frequency,
headache hours, headache duration, medication use, and improve-
ment. Follow-up periods varied from immediately post-treatment
to 36 months post-treatment. We attempted to contact the au-
thors of four RCTs to acquire additional data for analysis. We
were successful in obtaining such data in two cases (Tuchin 2000;
Whittingham 1997); however, we were unsuccessful in contacting
the authors in the other two cases (Parker 1980; Reich 1989).
Seven trials (total n = 1593) assessed four types of non-invasive
physical treatments for migraine headache: spinal manipulation
(Nelson 1998; Parker 1980; Tuchin 2000), physical treatment
combinations (Marcus 1998), TENS (Reich 1989), and pulsating
electromagnetic fields (PEMF) (Sherman 1998; Sherman 1999).
Four to 16 treatments were given over a period of 2 to 8 weeks. One
study did not specify the number of treatments or the treatment
period (Reich 1989).
Eight trials (total n = 1504) assessed five types of non-invasive
physical treatments for tension-type headache: spinal manipula-
tion (Boline 1995; Bove 1998; Hoyt 1979), physical treatment
combinations (Ahonen 1984; Carlsson 1990), cranial electrother-
apy (Solomon 1989), a combination of TENS and electrical neu-
rotransmitter modulation (Reich 1989), and therapeutic touch
(Keller 1986). One to 12 treatments were performed over 1 to 6
weeks. (Reich 1989 did not specify the number of treatments or
the treatment period.)
Six trials (total n = 461) assessed five types of non-invasive
physical treatments for cervicogenic headache: spinal manipu-
lation (Ammer 1990; Howe 1983; Jull 2002; Nilsson 1997;
Whittingham 1997), massage (Nilsson 1997), exercise therapy
(Jull 2002), mobilization (Bitterli 1977), and physical treatment
combinations (Ammer 1990; Jull 2002). One to 12 treatments
were provided over a period of 1 to 6 weeks.
Two trials (total n = 85) assessed two types of non-invasive physical
treatments for headaches that could not be classified according to
IHS categories. One trial assessed post-traumatic headache (Jensen
1990) and compared mobilization to cold packs. Two treatments
7Non-invasive physical treatments for chronic/recurrent headache (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
were given over 2 weeks. One trial assessed mixed headache (mi-
graine/tension-type) (Solomon 1985) and compared cranial elec-
trotherapy to placebo immediately after one treatment.
Risk of bias in included studies
The two methodological quality scores are reported for each study
in Table 2 (A-H), Table 3 (J-P), and Table 4 (R-Z). Limitations
of individual higher-quality trials (validity score = 40 or more) are
described below, under ’Results’.
Effects of interventions
Results are organized by headache type. The study design, in-
terventions, outcome measures, and results, as reported by study
investigators, are described for each study in the ’Characteristics
of included studies’ table. We used these data to calculate effect
sizes and percentage point differences for the purpose of this re-
view. Summaries of effect sizes and percentage point differences
for the various treatment comparisons and outcomes are provided
in Table 5 through Table 6 (according to headache type). A pos-
itive effect size favors the treatment group over the comparison
group. In the following discussion of individual studies, results
for the primary systematic review outcomes (headache pain and/
or headache index) are described first for each study, followed by
results for secondary outcomes. Effect sizes (ESs) and 95% confi-
dence intervals (CIs) are also reported.
In many cases, even relatively high-quality trials (validity score = 40
or more) had limitations that may affect the interpretation of study
results; these limitations are discussed below. Studies with lower
quality scores are acknowledged as having substantial limitations,
which are specifically described in Table 2 through Table 4.
Migraine headache (IHS category 1)
See Table 5 for a summary of treatment comparisons and results
for migraine headache.
Spinal manipulation therapy
Three trials evaluated the effect of spinal manipulation therapy
(SMT): Nelson 1998 (n = 218, validity score [VS] = 91), Parker
1980 (n = 88, VS = 67), and Tuchin 2000 (n = 127, VS = 38).
Nelson 1998 (n = 218, VS = 91) compared SMT to the commonly
used and efficacious drug amitriptyline (Bank 1994); the same
study also compared a combination of SMT plus amitriptyline
to amitriptyline alone. The 8 weeks of treatment consisted of 14
sessions of SMT and/or 100 mg of amitriptyline per day. Our
analysis showed similar reductions in headache index (ES -0.1;
95% CI -0.5 to 0.3) and pain medication use (ES -0.2; 95% CI -
0.6 to 0.2) in the SMT and amitriptyline groups during the last 4
weeks of treatment. However, during the 4-week post-treatment
period, patients in the SMT group recorded a significantly greater
reduction in headache index than patients in the amitriptyline
group (ES 0.4; 95% CI 0.0 to 0.8); pain medication use was
again similar in the two groups (ES 0.2; 95% CI -0.2 to 0.6).
The combination of SMT plus amitriptyline was no better than
amitriptyline alone for headache index or medication use at either
time point (see Table 5 for effect sizes).
This study had several limitations that may affect the interpreta-
tion of these findings. One concern is the substantial loss of pa-
tients to follow up (28%). The missing data analysis performed
may not have fully compensated for the loss of data. Moreover,
the withdrawal of amitriptyline at the end of treatment in this
study is inconsistent with normal clinical practice, and the return
of the amitriptyline patients to near baseline values on the main
outcomes at 4 weeks post-treatment could be due to a medica-
tion rebound effect, making the apparent advantage of the SMT
group less obvious. Similarly, this may explain why the SMT plus
amitriptyline combination therapy did not outperform amitripty-
line alone.
In Parker 1980 (n = 88, VS = 67), SMT provided by chiropractors
was compared to (a) SMT provided by medical doctors or physical
therapists and (b) mobilization provided by medical doctors or
physical therapists. Treatment was provided in up to two sessions
per week for 8 weeks. At 8 weeks post-treatment, we found that
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SMT provided by chiropractors was more favorable than mobi-
lization for headache pain intensity (ES 0.4; 95% CI -0.2 to 1.0),
but not for disability, duration, or frequency (ES for all three out-
comes 0.1; 95% CI -0.5 to 0.7).
There was no description of dropouts in this study, and there
is substantial uncertainty about the data integrity and statistical
analysis, so the likelihood of bias is an issue. We were unable to
access the original data. Based on the magnitude of the group dif-
ference, the chiropractic SMT group appeared to be superior to
the medical doctors/physical therapist SMT group on pain inten-
sity, but no F-ratios were presented. When the authors combined
data from the two SMT groups, the effect was similar to the mo-
bilization group on all outcomes (based on imputed effect sizes
from F-ratios). There was inadequate statistical power to detect a
clinically important effect size. The data provided did not allow us
to calculate ESs for the comparison of the two SMT groups with
one another, or for the comparison of SMT provided by medical
doctors/physical therapists with mobilization by medical doctors/
physical therapists.
Tuchin 2000 (n = 127, VS = 38) compared SMT with detuned
interferential therapy (placebo electrotherapy). Patients received
SMT up to 16 times over 8 weeks; frequency of placebo therapy
was unspecified. There was no statistically significant difference
between SMT and placebo for headache pain at 8 weeks post-
treatment (ES -0.4; 95% CI -0.8 to 0.1). However, SMT resulted
in statistically significant lower headache frequency (ES 0.5; 95%
CI 0.1 to 0.9), duration (ES 0.5; 95% CI 0.1 to 0.9), and medi-
cation use (ES 0.6; 95% CI 0.3 to 1.0).
The three studies were too dissimilar for their results to be pooled.
Summary of levels of evidence:
• There is preliminary evidence that SMT and amitriptyline
have a similar effect in reducing headache index during 8 weeks
of treatment, and moderate evidence that SMT is superior to
amitriptyline for the same outcome during the 4-week post-
treatment period. There is preliminary evidence that the
treatments result in similar reduction of non-prescription pain
medication use at both time points (evidence from one trial:
Nelson 1998).
• There is preliminary evidence that SMT plus amitriptyline
is at best similar to amitriptyline alone (evidence of inefficacy)
for headache index and pain medication use at both time points
(evidence from one trial: Nelson 1998).
• There is preliminary evidence that SMT is superior to
mobilization for pain, and that the interventions are similar for
disability, frequency, and duration at 8 weeks post-treatment.
However, the efficacy of mobilization is unknown (evidence
from one trial: Parker 1980).
• There is limited evidence that SMT is at best similar to
sham interferential therapy (evidence of inefficacy) for reducing
headache intensity at 2 months post-treatment, and limited
evidence that SMT is superior to the sham therapy for reducing
headache frequency, duration, and non-prescription pain
medication use at the same time point (evidence from one trial:
Tuchin 2000).
Pulsating electromagnetic fields
Two trials evaluated the effect of pulsating electromagnetic fields
(PEMF): Sherman 1998 (n = 12, VS = 50) and Sherman 1999 (n
= 48, VS = 39).
Sherman 1998 (n = 12, VS = 50) compared PEMF to placebo
PEMF using a crossover trial design. Each 2-week treatment period
consisted of ten 1-hour sessions during which the interventions
were applied to the medial thigh. Patients who received PEMF
experienced a greater reduction in the number of headaches per
week after 2 weeks of treatment than patients who received placebo
PEMF (ES 1.1; 95% CI -0.2 to 2.3).
This small pilot study had 12 participants, of which three patients
in the PEMF group inadvertently received treatments at half the
intended intensity. This study was intended only to provide infor-
mation about the feasibility of performing an adequately powered
trial.
In a subsequent larger study (Sherman 1999; n = 48, VS = 39), the
same group of investigators compared PEMF to placebo PEMF
using a parallel-group design. Each 2-week treatment period con-
sisted of ten 1-hour sessions during which the interventions were
applied to the medial thigh. The PEMF group experienced a sig-
nificantly greater decrease in headache activity index scores than
did the placebo PEMF group at 1 month post-treatment (ES 0.9;
95% CI 0.2 to 1.5).
The two studies were too dissimilar for their results to be pooled.
Summary of levels of evidence:
• There is preliminary evidence that PEMF is superior to
placebo PEMF in reducing headache frequency after 2 weeks of
treatment (evidence from one trial: Sherman 1998).
• There is limited evidence that PEMF is superior to placebo
PEMF on the headache activity score at 1 month post-treatment
(evidence from one trial: Sherman 1999).
Physical treatment combinations
Two trials evaluated physical treatment combinations: Marcus
1998 (n = 88, VS = 33) and Reich 1989 (n = 392, VS = 29).
Marcus 1998 (n = 88, VS = 33) compared a combination of home
exercise, stretching, and heat/ice to biofeedback/relaxation. The
4-week treatment schedule included a home regimen twice per
day and weekly 1-hour treatment sessions with a therapist. Signif-
icantly fewer patients in the home exercise, stretching, and heat/
ice group experienced a 50% reduction in headache index score
(mean headache severity over 2 weeks) compared to the relaxation
and biofeedback group following 4 weeks of treatment (ES -0.8;
95% CI -1.3 to -0.3). The mean reduction in the headache index
score from baseline was also significantly less for the home exercise,
stretching, and heat/ice group (ES -0.6; 95% CI -1.1 to -0.1).
Reich 1989 (n = 392, VS = 29) compared electrical modalities
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including TENS and electrical neurotransmitter modulation to
relaxation, biofeedback, and an unspecified combination of two
of these three treatments. Treatment lasted 4 weeks. It is unclear
how many treatments were provided on average. It appears that
some patients got fewer than and some more than 15 treatment
sessions. Follow up was after 4 weeks of treatment and 36 months
later. Effect sizes could not be calculated from the data. However,
group differences in percentage points suggest that a combination
of TENS and electrical neurotransmitter modulation is inferior to
biofeedback and superior to relaxation for reduction of headache
pain following 4 weeks of treatment and 36 months later. Us-
ing omnibus statistical tests, Reich found significant differences in
headache pain and duration between groups, with the relaxation
group having the worst and the biofeedback group the best out-
comes.
The two studies were too dissimilar for their results to be pooled.
Summary of levels of evidence:
• There is limited evidence that a combination of home
exercise, stretching, and heat/ice is inferior to biofeedback/
relaxation for reducing pain severity following 4 weeks of
treatment (evidence from one trial: Marcus 1998).
• There is preliminary evidence that a combination of TENS
and electrical neurotransmitter modulation is inferior to
biofeedback and superior to relaxation for reduction of headache
pain after 4 weeks of treatment and 36 months later (evidence
from one trial: Reich 1989).
Tension-type headache (IHS category 2)
See Table 7 for a summary of treatment comparisons and results
for tesnion-type headache.
Spinal manipulation therapy
Two trials evaluated spinal manipulation therapy (SMT) for ten-
sion-type headache (TTH): Boline 1995 (n = 150, VS = 91) and
Hoyt 1979 (n = 22, VS = 44).
Boline 1995 (n = 150, VS = 91) compared SMT to the commonly
used efficacious drug amitriptyline (Holroyd 2001) for chronic
TTH. Treatment lasted 6 weeks. The SMT group had two 20-
minute sessions per week including SMT, 5 to 10 minutes of moist
heat and 2 minutes of light massage. For the amitriptyline group,
the medication dosage was 10 mg per day in the first week, 20
mg per day in the second week, and 30 mg per day each week
thereafter. At the end of a 6-week treatment period, the SMT
group had higher pain intensity (ES -0.4; 95% CI -0.8 to 0.0)
but reported fewer side effects. The two therapies were similar
for headache frequency (ES -0.3; 95% CI -0.7 to 0.1) and non-
prescription medication use (ES -0.2; 95% CI -0.6 to 0.2) at
this same time point. However, 4 weeks post-treatment, the SMT
group performed significantly better in terms of headache pain
intensity (ES 0.6; 95% CI 0.2 to 1.0), frequency (ES 0.5; 95% CI
0.1 to 0.9), and non-prescription medication use (ES 0.5; 95%
CI 0.1 to 0.9).
There is a concern with the medication intervention in this trial.
The withdrawal of amitriptyline at the end of treatment is incon-
sistent with normal clinical practice, and the return of these pa-
tients to near baseline values at 4 weeks post-treatment could be
due to a medication rebound effect, making the reported advan-
tage of the SMT group less valid.
Hoyt 1979 (n = 22, VS = 44) compared SMT to two no-treat-
ment controls (palpation and rest). Each intervention consisted
of a single 10-minute session. Significantly more pain reduction
was observed in the SMT group than in the other groups imme-
diately following treatment (ES 1.8; 95% CI 0.4 to 3.2 for both
comparisons). Since the study assessed only the immediate effects
of a single treatment, it provides little information about the role
of SMT in the management of chronic/recurrent headache.
The two studies were too dissimilar for their results to be pooled.
Summary of levels of evidence:
• There is moderate evidence that SMT is inferior to
amitriptyline for pain intensity during 6 weeks of treatment.
There is also preliminary evidence for similarity of the treatments
for frequency and non-prescription medication use during
treatment. However, for the 4-week post-treatment period, there
is moderate evidence showing that SMT is superior to
amitriptyline for pain intensity, frequency, and non-prescription
pain medication use (evidence from one trial: Boline 1995).
• There is limited evidence indicating that SMT is superior to
no treatment (palpation or rest) for pain reduction immediately
after a single treatment (evidence from one trial: Hoyt 1979).
Cranial electrotherapy
One trial evaluated cranial electrotherapy (CE): Solomon 1989 (n
= 112, VS = 42) compared CE to placebo CE. Patients received 20-
minute treatments for individual headache episodes using a home
headache suppressor unit for 6 to 10 weeks. At the end of this pe-
riod, participants receiving the active CE had significantly greater
improvements in pain intensity than those receiving placebo CE
(ES 0.4; 95% CI 0.0 to 0.8).
There is an important limitation. It is uncertain what impact the
group differences in important baseline characteristics (e.g., dura-
tion in hours of headaches) had on the final outcomes in this trial.
Summary of levels of evidence:
• There is limited evidence showing that CE is superior to a
placebo CE for pain intensity after 6 to 10 weeks of treatment
(evidence from one trial: Solomon 1989).
Therapeutic touch
10Non-invasive physical treatments for chronic/recurrent headache (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
One trial evaluated therapeutic touch: Keller 1986 (n = 60, VS =
50) compared one session of therapeutic touch (intention to heal
by near-touching) plus rest and deep breathing to placebo thera-
peutic touch plus rest and deep breathing. Large and statistically
significant lower pain ratings were observed 5 minutes (ES 1.1;
95% CI 0.5 to 1.6) and 4 hours (ES 0.8; 95% CI 0.2 to 1.3) post-
treatment in patients receiving therapeutic touch.
Since the study assessed only the effects within hours of the appli-
cation of a single treatment, it provides little information about
the role of this treatment in the management of chronic/recurrent
headache. The study was also limited by lack of blinding of the
therapist.
Summary of levels of evidence:
• There is moderate evidence that therapeutic touch is
superior to placebo therapeutic touch for pain reduction within a
few hours of a single treatment (evidence from one trial: Keller
1986).
Physical treatment combinations
Four trials evaluated physical treatment combinations: Ahonen
1984 (n = 22, VS = 40), Bove 1998 (n = 75, VS = 58), Carlsson
1990 (n = 48, VS = 21), and Reich 1989 (n = 311, VS = 29).
Ahonen 1984 (n = 22, VS = 40) compared a combination of mas-
sage, ultrasound, and hot packs to acupuncture. Treatment lasted
3 weeks. The combination therapy group received three sessions
of massage and parafango (warm paraffin and mud), followed by
five sessions of massage and ultrasound. The acupuncture group
received four sessions of care. For pain reduction, the combination
therapy was similar to acupuncture at the end of treatment (ES -
0.1; 95% CI, -1.0 to 0.8) and 20 weeks later (ES 0.2; 95% CI -
0.7 to 1.1); at 8 weeks post-treatment the combination therapy
was inferior (ES -0.6; 95% CI -1.5 to 0.3). The group differences
were not statistically significant. This study was substantially un-
derpowered, producing highly uncertain results.
Bove 1998 (n = 75, VS = 58) compared a combination of SMT
and massage to placebo laser plus massage. The treatment regi-
men was eight 15-minute sessions over 4 weeks. High-velocity,
low-amplitude SMT was administered. Massage consisted of deep
friction massage and trigger point therapy to the muscles of the
neck and shoulders. For headache intensity, outcomes favored the
comparison group, although no significant differences were found
at 1 week (ES -0.3; 95% CI -0.8 to 0.2) or 3 months (ES -0.4;
95% CI -0.9 to 0.1) after treatment. There were no notable dif-
ferences between groups for daily analgesic use or headache hours
at the two time points (see Table 7 for ESs).
The authors concluded that SMT alone does not have a positive
effect on episodic tension-type headache. By its design, the trial
did not assess the isolated effect of SMT; rather, it examined the
combined effect of SMT and soft tissue massage. Whether there
is an interaction that results from combining SMT with soft tis-
sue massage is unknown. A more appropriate conclusion would
have been that SMT, when combined with soft tissue massage,
is no better than soft tissue therapy alone for episodic tension-
type headache. This conclusion neither supports nor refutes the
efficacy of SMT as a separate therapy.
Carlsson 1990 (n = 48, VS = 21) compared a regimen of relaxation,
auto-massage, TENS, and stretching to acupuncture. The regimen
group received 10 to 12 sessions given over 8 to 12 weeks, and the
acupuncture group received 4 to 10 sessions over 2 to 8 weeks.
The combination group experienced significantly less headache
pain intensity 4 to 9 weeks post-treatment (ES 0.7; 95% CI 0.1
to 1.3). No significant differences were observed between groups
for headache frequency (ES -0.1; 95% CI -0.7 to 0.4).
Reich 1989 (n = 311, VS = 29) compared electrical modalities
including TENS and electrical neurotransmitter modulation with
relaxation, biofeedback, and an unspecified combination of two
of these three treatments. Treatment lasted 4 weeks. It is unclear
how many treatments were provided on average. It appears that
some patients got fewer than and some more than 15 treatment
sessions. Effect sizes could not be calculated from the data. Follow
up was after 4 weeks of treatment and 36 months later. Significant
differences in headache pain and frequency were noted between
groups using omnibus statistical tests, with the relaxation group
doing the worst and the biofeedback group doing the best. The
biofeedback group had better outcomes than the combination
electrical modalities group. The multi-modal group had similar
outcomes to the combination group.
The four studies were too dissimilar for their results to be pooled.
Summary of levels of evidence:
• There is preliminary evidence that a regimen of massage,
ultrasound, and hot packs is similar in effect to acupuncture at
the end of 3 weeks of treatment for pain reduction, inferior to
acupuncture at 8 weeks, and similar at 20 weeks post-treatment
(evidence from one trial: Ahonen 1984).
• There is moderate evidence showing that SMT added to
massage is at most similar in effect to placebo laser added to
massage (evidence of inefficacy) for headache intensity 1 week
after a 4-week treatment period, and preliminary evidence that
the combination of SMT and massage is inferior at 3 months
following treatment. There is preliminary evidence of similarity
for duration and daily analgesics at the two time points (evidence
from one trial: Bove 1998).
• There is limited evidence that a regimen of auto-massage,
TENS, and stretching is superior to acupuncture for pain relief 4
to 9 weeks post-treatment. There is preliminary evidence that the
treatments are similar for headache frequency at the same time
point (evidence from one trial: Carlsson 1990).
• There is preliminary evidence that a combination of TENS
and electrical neurotransmitter modulation is similar to
biofeedback and to relaxation for reduction of headache pain
after 4 weeks of treatment. There is preliminary evidence that the
combination therapy is inferior to biofeedback and superior to
relaxation for pain reduction 36 months later (evidence from one
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trial: Reich 1989).
Cervicogenic headache (IHS category 11.2)
See Table 8 for a summary of treatment comparisons and results
for cervicogenic headache.
Spinal manipulation therapy
Five studies evaluated spinal manipulation therapy (SMT) for cer-
vicogenic headache: Bitterli 1977 (n = 30, VS = 29), Howe 1983
(n = 27, VS = 25), Jull 2002 (n = 200, VS = 75), Nilsson 1997 (n
= 54, VS = 65), and Whittingham 1997 (n = 105, VS = 54).
Bitterli 1977 (n = 30, VS = 29) compared 3 weeks of SMT, mo-
bilization, and a wait-list control. The SMT group averaged 3.8
sessions and the mobilization group 3.2 sessions. At the end of
treatment, patients receiving SMT had greater pain reduction than
those receiving mobilization (ES 0.4; 95% CI -0.5 to 1.4) or those
put on a wait-list (ES 0.6; 95% CI -0.4 to 1.5). Results were not
statistically significant (insufficient power). Three months after
treatment, there was no difference between SMT and mobiliza-
tion (ES -0.1; 95% CI -1.0 to 0.8).
The study by Howe et al (Howe 1983) (n = 27, VS = 25) compared
SMT plus NSAIDs to NSAIDs alone for neck-related headache
(IHS category 11.2). Treatment was provided for up to 3 weeks,
but the number of treatments was not specified. More patients re-
ceiving one session of SMT plus NSAIDs reported improvement
than those receiving NSAIDs alone (ES 0.5; 95% CI -0.5 to 1.5);
this difference was not statistically significant. There were no dif-
ferences between the two groups after 1 week (ES 0.1; 95% CI -
0.9 to 1.1) or 3 weeks of care (ES -0.1; 95% CI -1.1 to 0.9).
Jull 2002 (n = 200, VS = 75) compared 6 weeks of SMT (high- and
low-velocity), exercise (endurance, isometric, and stretching), a
combination of the two, and a no-treatment control. At 1 week and
12 months post-treatment, the SMT group showed significantly
more reduction in pain intensity (ES [with 95% CI] at 1 week
0.7 [0.3 to 1.2]; at 12 months 0.4 [0.0 to 0.8]) and headache
frequency (ES 0.7; 95% CI 0.3 to 1.1 at both time points) than
the no-treatment control group. SMT performed little better than
no treatment in terms of headache duration (see Table 8 for ESs).
Compared to exercise, SMT showed similar reductions in pain
(ES [with 95% CI] at 1 week -0.1 [-0.5 to 0.3]; at 12 months -
0.2 [-0.6 to 0.2]), headache frequency (ES [with 95% CI] at 1
week -0.2 [-0.6 to 0.2]; at 12 months -0.1 [-0.5 to 0.3]), and
headache duration (ES [with 95% CI] at 1 week 0.3 [-0.2 to 0.8];
at 12 months 0.1 [-0.3 to 0.5]); these results were not statistically
significant.
In this study, numerous statistical tests were performed at several
time points without adjustments for the increased likelihood of
spurious results.
Nilsson 1997 (n = 54, VS = 65) compared SMT to massage plus
placebo laser. There were six sessions of care in 3 weeks. SMT con-
sisted of standard ’diversified’ manipulation in the lower cervical
region and ’toggle recoil’ in the upper region. The massage group
received deep friction massage and trigger point therapy. There
was a significantly greater decrease in pain intensity (ES 0.6; 95%
CI 0.1 to 1.1) and headache hours (ES 0.5; 95% CI 0.0 to 1.0)
in the SMT group at 1 week post-treatment. The advantage for
SMT in number of pain killers (pills per day) was not significant
(ES 0.3; 95% CI -0.2 to 0.8).
This extended trial is unorthodox in that the decision to recruit
more patients was made after the original analyses of the data for
the purpose of increasing statistical power. No pre-specifications
were made regarding separate analyses of the data and no statistical
adjustments were made for multiple looks at the data.
Whittingham 1997 (n = 105, VS = 54) compared SMT with
placebo SMT. ’Toggle recoil’ manipulation was administered to
the upper cervical region three times per week for 3 weeks. Placebo
manipulation consisted of treatment to the same region with a
deactivated mechanical instrument. There were significant differ-
ences in favor of SMT after 3 weeks of treatment for pain intensity
(ES 2.2; 95% CI 1.7 to 2.7), disability (ES 1.0; 95% CI 0.6 to
1.5), and number of headache locations (ES 1.1; 95% CI 0.7 to
1.5).
This study was designed as a crossover trial, but due to the presence
of both carryover and time effects, only the first phase of the trial
contributed to the conclusions.
The five studies were too dissimilar for their results to be pooled.
Summary of levels of evidence:
• There is preliminary evidence that SMT is superior to
mobilization and to a wait-list control for pain reduction after 3
weeks of treatment, and similar to mobilization at 3 months
post-treatment (evidence from one trial: Bitterli 1977).
• There is preliminary evidence that SMT plus NSAIDs is
superior to NSAIDs alone for headache improvement after 1
treatment, and similar to NSAIDs at the end of 1 week and 3
weeks of treatment (evidence from one trial: Howe 1983).
• There is moderate evidence that SMT is superior to no
treatment in reducing headache pain and frequency 1 week and
12 months following 6 weeks of treatment. There is also
preliminary evidence that SMT is similar to no treatment for
headache duration (evidence from one trial: Jull 2002).
• There is preliminary evidence that SMT is at most similar
to exercise for headache pain and frequency. There is moderate
evidence showing that SMT is at least similar to exercise for
headache duration at both time points (evidence from one trial:
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Jull 2002).
• There is moderate evidence showing SMT is superior to
massage plus placebo laser for pain and headache hours at 1 week
following 3 weeks of care, and SMT is at least similar to massage
plus placebo laser for medication use (evidence from one trial:
Nilsson 1997).
• There is moderate evidence indicating that SMT is superior
to placebo SMT for pain, disability, and number of headache
sites after 3 weeks of treatment (evidence from one trial:
Whittingham 1997).
Massage
One trial evaluated the effect of massage: Nilsson 1997 (n = 54,
VS = 65) compared massage plus placebo laser to SMT. There
were six sessions of care in 3 weeks. The massage group received
deep friction massage and trigger point therapy. SMT consisted
of standard ’diversified’ manipulation in the lower cervical region
and ’toggle recoil’ in the upper region. There was a significantly
smaller decrease in pain intensity (ES -0.6; 95% CI -1.1 to -0.1)
and headache hours (ES -0.5; 95% CI -1.0 to 0.0) for the massage
group at 1 week post-treatment . The difference between groups
for number of pain killers (pills per day) was not significant (ES -
0.3; 95% CI -0.8 to 0.2).
This extended trial is unorthodox in that the decision to recruit
more patients was made after the original analyses of the data for
the purpose of increasing statistical power. No pre-specifications
were made regarding separate analyses of the data and no statistical
adjustments were made for multiple looks at the data.
Summary of levels of evidence:
• There is moderate evidence that massage plus placebo laser
is inferior to SMT for pain and headache hours at 1 week
following 3 weeks of care. There is also preliminary evidence that
the treatments are at most similar for medication use (evidence
from one trial: Nilsson 1997).
Exercise therapy
One trial evaluated the effect of exercise therapy (Jull 2002; n =
200, VS = 75). This study compared 6 weeks of exercise therapy
(endurance, isometric, and stretching), SMT (high- and low-ve-
locity), a combination of the two, and a no-treatment control. At
1 week and 12 months post-treatment, the exercise group showed
significantly greater reductions in pain intensity and headache fre-
quency than did the no-treatment control group. Effect sizes (with
95% CIs) were: for pain intensity at 1 week, 0.8 (0.3 to 1.2); for
pain intensity at 12 months, 0.6 (0.2 to 1.0); and for headache fre-
quency, 1.0 (0.5 to 1.4) for both time points. Exercise performed
no better than no treatment in terms of headache duration (see
Table 8 for ESs). Compared to SMT, exercise showed similar re-
ductions in pain (ES [with 95% CI] at 1 week 0.1 [-0.3 to 0.5]; at
12 months 0.2 [-0.2 to 0.6]), headache frequency (ES [with 95%
CI] at 1 week 0.2 [-0.2 to 0.6]; at 12 months 0.1 [-0.3 to 0.5]),
and headache duration (ES [with 95% CI] at 1 week -0.3 [-0.8
to 0.2]; at 12 months -0.1 [-0.5 to 0.3]); these results were not
statistically significant.
In this study, numerous statistical tests were performed at several
time points without adjustments for the increased likelihood of
spurious results.
Summary of levels of evidence:
• There is moderate evidence for short-term and long-term
absolute efficacy indicating that exercise is superior to no
treatment in reducing headache pain and frequency 1 week and
12 months following 6 weeks of treatment. There is preliminary
evidence that exercise is similar to no treatment for headache
duration at the two time points (evidence from one trial: Jull
2002).
• There is moderate evidence showing that exercise is at least
similar to manipulation for headache pain and frequency 1 week
and 12 months following 6 weeks of treatment. There is also
preliminary evidence for similarity in headache duration at the
two time points (evidence one trial: Jull 2002).
Mobilization
One trial evaluated mobilization: Bitterli 1977 (n = 30, VS = 29)
compared 3 weeks of mobilization, SMT, and a wait-list control.
The mobilization group averaged 3.2 sessions and the SMT group
averaged 3.8 sessions. At the end of treatment, patients receiving
mobilization had less pain reduction than those receiving SMT (ES
-0.4; 95% CI -1.3 to 0.5). There was also no difference between
mobilization and wait-list control at the end of treatment (ES
0.1; 95% CI -0.8 to 1.0). Results were not statistically significant
(insufficient power). Three months after treatment, there was no
difference between mobilization and SMT (ES 0.1; 95% CI -0.8
to 1.0).
Summary of levels of evidence:
• There is preliminary evidence that mobilization is inferior
to spinal manipulation for pain reduction at the end of 3 weeks
of treatment, and similar to manipulation 3 months later
(evidence from one trial: Bitterli 1977).
• There is preliminary evidence that mobilization is similar to
a wait-list control at the end of 3 weeks of treatment (evidence
from one trial: Bitterli 1977).
Physical treatment combinations
Two trials evaluated physical treatment combinations: Ammer
1990 (n = 45, VS = 50) and Jull 2002 (n = 200, VS = 75).
Ammer 1990 (n = 45, VS = 50) compared three regimens: SMT
plus pulsed galvanic current applied to the neck; massage with
herbal moist pack applied to the neck and shoulders; and a combi-
nation of ultrasound and UV light applied to the neck with direct
galvanic current applied to the neck and forehead. All treatment
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was provided in 10 sessions over 2 weeks. At the end of treatment,
there were no statistically significant differences between groups
on patient-rated headache improvement (insufficient power) (ES
[95% CI] versus galvanic current + ultrasound/UV light 0.4 [-0.4
to 1.1]; versus massage + herbal pack 0.5 [-0.3 to 1.3]). There were
no important differences between the latter two groups (ES 0.1;
95% CI -0.6 to 0.9).
The results of this trial are limited by the use of a non-validated out-
come measure of patient-rated improvement, thus making mag-
nitude of within- and between-group differences difficult to com-
pare with those from other trials.
Jull 2002 (n = 200, VS = 75) compared 6 weeks of SMT (high-
and low-velocity), exercise (endurance, isometric, and stretching),
a combination of SMT and exercise interventions, and a no-treat-
ment control. SMT plus exercise versus no treatment: At 1 week
and 12 months post-treatment, the combination therapy pro-
duced significantly better reduction of headache pain intensity (ES
[95% CI] at 1 week 0.8 [0.4 to 1.2]; at 12 months 0.6 [0.2 to
1.0]), frequency (ES [95% CI] at 1 week 0.7 [0.3 to 1.1]; at 12
months 0.7 [ 0.3 to 1.2]), and duration (ES 0.5; 95% CI 0.1 to
0.9 for both time points). SMT plus exercise versus exercise alone:
There were no significant differences for headache pain (ES [95%
CI] at 1 week, 0.0 [-0.4 to 0.4]; at 12 months, -0.1 [-0.5 to 0.3])
or frequency (ES -0.2; 95% CI -0.6 to 0.2 for both time points).
SMT plus exercise was significantly better than exercise alone only
for headache duration (ES [95% CI] at 1 week 0.5 [0.1 to 0.9]; at
12 months 0.4 [0.0 to 0.8]). SMT plus exercise versus SMT alone:
There were no notable differences between the groups for pain,
frequency, or duration at either 1-week or 1-year time points (ES
ranged between 0.3 and -0.1; 95% CIs not statistically significant;
see Table 8).
In this study, numerous statistical tests were performed at several
time points without adjustments for the increased likelihood of
spurious results.
The two studies were too dissimilar for their results to be pooled.
Summary of levels of evidence:
• There is preliminary evidence that SMT plus galvanic
current is superior to a combination of galvanic current,
ultrasound, and UV light and to a combination of massage and
moist herbal packs for headache improvement at the end of 2
weeks of treatment. There is preliminary evidence that the latter
two groups are similar in effect (evidence from one trial: Ammer
1990).
• There is moderate evidence showing that SMT plus exercise
is superior to no treatment in reducing headache pain, frequency,
and headache duration at 1 week and 12 months following 6
weeks of treatment. (evidence from one trial: Jull 2002).
• There is preliminary evidence that the SMT plus exercise is
similar to exercise alone for headache pain at 1 week following
treatment, and moderate evidence that the combination is at
most similar to exercise alone at 12 months after treatment.
There is moderate evidence that SMT plus exercise is at most
similar to exercise alone for frequency at the two time points.
However, there is moderate evidence showing that the
combination is superior to exercise alone for headache duration
at the two time points (evidence from one trial: Jull 2002). This
means, that except for headache duration, there is no advantage
to adding SMT to exercise over exercise alone (evidence of
inefficacy).
• There is preliminary evidence that SMT plus exercise is
similar to SMT alone for headache pain intensity, frequency, and
duration at the 2 time points (evidence from one trial: Jull
2002). This means there is no advantage to adding exercise to
SMT over SMT alone (evidence of inefficacy).
Headache not classifiable (IHS category 13)
See Table 6 for a summary of treatment comparisons and results
for headache not classifiable.
Cranial electrotherapy for mixed headache
(migraine/tension-type)
One trial evaluated cranial electrotherapy (CE): Solomon 1985 (n
= 62, VS = 19) compared a single 15-minute session of CE-per-
ceived stimulus, CE-subliminal stimulus, and placebo (detuned)
CE. There was significantly lower pain intensity in the CE-per-
ceived stimulus group than in the placebo CE group immedi-
ately following one treatment (ES 0.7; 95% CI 0.1 to 1.3). There
was no significant difference between CE-subliminal stimulus and
placebo (ES 0.1; 95% CI -0.5 to 0.7); there was lower pain inten-
sity in the CE-perceived stimulus versus the CE-subliminal (ES
0.6; 95% CI -0.1 to 1.3). The study was underpowered. It was
not possible to extract data allowing separate analysis of migraine
and/or tension-type headache.
Summary of levels of evidence:
• There is limited evidence for absolute efficacy showing that
CE-perceived stimulus is superior to placebo CE for pain
intensity immediately following one treatment. There is
preliminary evidence that perceived stimulus CE is superior to
subliminal stimulus CE (evidence from one trial: Solomon
1985).
• There is preliminary evidence of similarity between CE-
subliminal stimulus and placebo CE following one treatment
(evidence from one trial: Solomon 1985).
Mobilization for post-traumatic headache
One trial (Jensen 1990; n = 23, VS = 46) compared mobilization
to cold packs. Mobilization consisted of mobilization of specific
segments of the cervical and upper thoracic spine in combination
with ’muscle-energy’ techniques. Cold packs were applied to neck
and shoulders for 15 to 20 minutes. There were two sessions per
week for 2 weeks. Mobilization patients did significantly better in
regards to headache pain intensity 3 weeks after treatment (ES 1.1;
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95% CI 0.1 to 2.0). There was no statistically significant difference
8 weeks after treatment (ES 0.4; 95% CI -0.5 to 1.2).
Interventions in both groups were performed by the principal
investigator and lead author of the study, making bias likely.
Summary of levels of evidence:
• There is limited evidence that mobilization is superior to
cold packs in reducing pain intensity 3 weeks following 2 weeks
of treatment, and preliminary evidence that mobilization is
superior 8 weeks after treatment (evidence from one trial: Jensen
1990).
Sensitivity analyses
Originally, sensitivity analyses were planned to examine the im-
pact of changing the validity scores using both our 20-item scale
and the Jadad scale. The correlation of the scores between the two
scales was 0.42. We decided that the Jadad scale was not suited
to form the basis of alternative evidence rules, so only one set of
sensitivity analyses was conducted to evaluate the effect of chang-
ing the methodological quality scores required for each level of
evidence (see Table 2, Table 3, Table 4).
Validity score
We examined the effect of changing the validity score requirement
for a specific evidence level ± 10 points (100-point quality scale)
for the review’s primary outcomes, headache pain and headache
index.
Lowering the score 10 points would increase the level of evidence
from ’limited’ to moderate’ for:
• Efficacy of SMT compared to no treatment for tension-type
headache (Hoyt 1979);
• Efficacy of cranial electrotherapy compared to placebo for
tension-type headache (Solomon 1989); and
• Efficacy of mobilization compared to cold packs for post-
traumatic headache (Jensen 1990).
Raising the score 10 points would reduce the level of evidence
from ’moderate’ to ’limited’ for:
• Efficacy of therapeutic touch compared to placebo
therapeutic touch for tension-type headache (Keller 1986);
• Inefficacy of adding manipulation compared to massage for
tension-type headache (Bove 1998); and
• Efficacy of SMT compared to placebo SMT for
cervicogenic headache (Whittingham 1997).
Overall, the sensitivity analyses showed that changing the rules of
evidence, in regard to the validity scores, would have had limited
impact on the overall conclusions of this review.
Effect size
We examined the effect of lowering or raising the point estimate
of the ES used in determining a clinically important difference
(classified as superiority or inferiority) for the review’s primary
outcomes, headache pain and headache index.
Increasing the ES criterion from ± 0.4 to ± 0.5 resulted in the
following changes:
• Moderate evidence of inefficacy of SMT compared to an
efficacious drug for tension-type headache during the treatment
phase would be raised to preliminary evidence of efficacy (Boline
1995).
• Moderate evidence of efficacy for SMT compared to no
treatment would become preliminary evidence of inefficacy for
cervicogenic headache at the 1-year follow-up point (Jull 2002).
• Preliminary evidence of efficacy for SMT compared to
mobilization would become preliminary evidence of similarity
with a therapy of unknown efficacy for migraine headache
(Parker 1980).
• Preliminary evidence of efficacy for SMT compared to
mobilization would become preliminary evidence of similarity
with a therapy of unknown efficacy for cervicogenic headache
(Bitterli 1977).
• Preliminary evidence of efficacy for mobilization compared
to cold packs would become preliminary evidence of similarity
with a therapy of unknown efficacy for post-traumatic headache
(Jensen 1990).
Decreasing the ES criterion from ± 0.4 to ± 0.3 did not change
the evidence from any of the studies.
Overall, the sensitivity analyses involving the effect size showed
that changing the rules of evidence, in regard to the threshold
for what was arbitrarily considered a group difference of clinical
importance, would have had relatively limited impact on the main
conclusions of this review.
D I S C U S S I O N
Clinical heterogeneity of the trials in terms of headache type, pa-
tient characteristics, interventions, comparison therapies, and out-
come measures prevented us from applying statistical pooling in
this review. IHS diagnostic categories 3-10 and 12 were not rep-
resented in any of the included trials.
Two trials could not be classified according to IHS diagnostic
categories. Jensen 1990 included patients with post-traumatic
headache, but apparently not as a result of head injury, and was,
therefore, not classifiable. In the study by Solomon et al, (Solomon
1985) it was not possible to extract data allowing separate analy-
sis of migraine, tension-type headache, or the combination of the
two.
None of the studies reviewed evaluated the cost-effectiveness of
the interventions for chronic/recurrent headaches.
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Limitations of the review
A possible limitation of the current review is publication bias, of
which there are several potential sources (Dickersin 1990). No
effort was made to identify unpublished research, which is more
likely to have negative outcomes (Cook 1993; Rosenthal 1979).
However, it is recognized that attempts to retrieve unpublished
data from trials are also likely to be biased (Rosenthal 1979). The
search strategy may have missed important studies not currently in-
dexed, but by including citation tracking of non-indexed journals
we should have kept such omissions to a minimum. Optimally,
reviews should include all trials regardless of language (Dickersin
1987; Gregoire 1995; Moher 1996). Although an attempt was
made to identify trials in all languages, the possibility that some
relevant trials may have been overlooked must be acknowledged.
Furthermore, the reliability of different methodological scoring
systems is a source of uncertainty (Oxman 1991). Conclusions
regarding the weight of evidence are dependent on the choice of
quality scoring system and on the exact definition of the evidence
classification system used (Moher 1995). Therefore, in addition to
our preferred 20-item scale, described above, we employed a com-
monly used methodological assessment tool, namely the five-point
scoring system developed by Jadad (Jadad 1996). This scale ad-
dresses three areas: randomization, double-blinding, and descrip-
tion of dropouts, which, if not addressed adequately, may be im-
portant sources of bias. The correlation between the total scores of
the two scoring systems was 0.42. The explanation for the relative
low correlation may be the proportionally high weight placed on
the importance of blinding both patients and treatment provider
in the Jadad scale compared to our 20-item scale. Complete blind-
ing for some of the treatments (e.g., spinal manipulation and mas-
sage) is inherently impossible or difficult to achieve.
Adverse reactions
The results of the trials included in this review do not suggest that
any of these therapies are associated with important risks of se-
vere adverse reactions. Side effects have been addressed mostly for
spinal manipulation. Individual estimates and the results of retro-
spective surveys consistently suggest a risk of serious cerebrovas-
cular complication of approximately one per one million cervical
manipulations (Haldeman 1999; Terrett 1992). Overall, serious
or severe complications from spinal manipulation seem to be very
rare, but because underreporting in the literature is a likely phe-
nomenon, and because some reports may have wrongly attributed
side effects to SMT when not established (Powell 1993), the ex-
isting estimates are associated with substantial uncertainty at this
time and can only be improved when data become available from
well designed prospective studies (Assendelft 1996b).
Magnitude of effects
Interpretation of the results of RCTs has traditionally focused on
the statistical significance, whereas the clinical importance of dif-
ferences between treatment and control has frequently been ig-
nored. Very little is known about what is considered by patients
to be a minimal clinically important change in headache outcome
measures such as pain and disability. However, a key question
needed to interpret the results of clinical trials is whether the mea-
sured standardized group difference in outcomes (effect size) is
clinically important. Sometimes, the minimal clinically important
difference is arbitrarily stipulated by investigators. Usually, authors
assume that if the mean difference between a treatment and con-
trol is appreciably less than the smallest pre-determined important
change, then the treatment had little or no effect. Conversely, it is
also assumed that if the observed mean difference between treat-
ments was substantially larger than the smallest important change,
most or all patients benefited from the treatment. This is not nec-
essarily true.
Benefit depends not only on differences between group means,
but also on the distribution of outcomes among patients within
each treatment group. Members of an international clinical sig-
nificance consensus group recently addressed this topic in a series
of publications (Guyatt 1998; Guyatt 2000; Guyatt 2002). They
concluded that no single approach to interpreting findings from
RCTs and systematic reviews is perfect. Authors too often draw
inappropriate conclusions when they declare treatment ineffec-
tiveness based solely on presence or absence of statistical differ-
ences between a test treatment and a control. To inform decisions
about management of individual patients, it may be much more
appropriate to think in terms of available treatment options which
have shown a meaningful clinical effect, rather than choosing or
discarding specific therapies based on mean group differences of
undefined clinical importance.
Systematic reviews
Several previously published systematic reviews have assessed the
effect of different non-invasive therapies for chronic/recurrent
headache. Except for migraine, which was not covered in the re-
views by Hurwitz et al (Hurwitz 1996), Vernon et al (Vernon
1999), McCrory et al (McCrory 2001), and Gross et al (Gross
2002), the conclusions of these reviews are similar to ours. Hurwitz
1996 and Gross 2002 focused primarily on the effectiveness of
manual treatment for neck pain but also reviewed what they
defined as neck-related headache using different criteria. The
acupuncture review by Melchart et al (Melchart 2001) came to
conclusions similar to ours regarding the effect of certain combi-
nations of physical treatments for tension-type headache.
A U T H O R S ’ C O N C L U S I O N S
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Implications for practice
The evidence for efficacy or inefficacy of the different non-invasive
physical treatments for the various types of headaches rests on sep-
arate individual trials. Thus the strength of the evidence never ex-
ceeded the moderate level. Ten studies had methodological quality
scores equal to or greater than 50, but many limitations were iden-
tified. A few additional high-quality randomized controlled trials
(RCTs) in the future could easily change the conclusions of our
review. Based on trial results, the non-invasive physical treatments
studied appear to be associated with little risk of serious adverse
effects. Their relative cost-effectiveness is not known.
For the prophylactic treatment of migraine headache, there is ev-
idence from a high-quality study that spinal manipulation may
be an effective treatment option with a short-term effect similar
to that of a commonly used, effective drug (amitriptyline). There
were fewer side effects associated with spinal manipulation. Com-
bining the two treatments does not seem to offer an advantage.
Weaker evidence from a lower-quality study showed that spinal
manipulation was ineffective in reducing pain, but was superior
to a sham interferential therapy for reducing headache frequency,
duration, and medication use. Other possible treatment options
with weaker evidence of effectiveness in pain reduction are pulsat-
ing electromagnetic fields in comparison to placebo; and a com-
bination of transcutaneous electrical nerve stimulation (TENS)
and electrical neurotransmitter modulation in comparison to re-
laxation training.
For the prophylactic treatment of chronic tension-type headache,
evidence from a high-quality study shows that a commonly used
drug provides more pain reduction in the short term than spinal
manipulation. There were fewer side effects associated with the
spinal manipulation. However, spinal manipulation appears supe-
rior to the drug after cessation of treatment by providing a sus-
tained short-term effect. Evidence from another high-quality study
shows that adding spinal manipulation to massage for episodic ten-
sion-type headache is not effective. Therapeutic touch may result
in immediate short-term pain reduction. Other possible treatment
options with weaker evidence of effectiveness in pain reduction
are cranial electrotherapy compared to placebo therapy; a com-
bination of TENS and electrical neurotransmitter modulation in
comparison to relaxation training; and a regimen of auto-massage,
TENS, and stretching in comparison to acupuncture.
For the prophylactic treatment of cervicogenic headache, there is
evidence from a high-quality study that both neck exercise (low-
intensity endurance training) and spinal manipulation are effec-
tive in reducing headache intensity and frequency in the short and
long term in comparison to no treatment. Except for reduction in
headache duration, there is no advantage to combining the two
therapies. From two more high-quality studies there is evidence
that spinal manipulation is effective in the short term in improv-
ing pain and other secondary headache outcomes in comparison
to massage or placebo spinal manipulation. Weaker evidence from
a lower-quality study showed that spinal manipulation was more
effective for pain reduction in the short term than spinal mobi-
lization or no treatment.
There is currently insufficient evidence to draw conclusions re-
garding the efficacy of any non-invasive physical treatments for
patients with a mix of migraine and tension-type headache.
There is some evidence that spinal mobilization may have better
short-term reduction in pain intensity than cold packs in the treat-
ment of post-traumatic headache.
No single approach to interpreting findings from RCTs and sys-
tematic reviews is perfect. To inform decisions about the manage-
ment of individual patients, it may be more appropriate to think in
terms of available treatment options that have shown a meaningful
clinical effect, rather than choosing or discarding specific thera-
pies solely based on mean group differences of undefined clinical
importance.
Implications for research
The heterogeneity of the studies included in this review means
that the results of a few additional high-quality RCTs in the future
could easily change the conclusions of our review.
More trials are needed to establish a firmer basis for considering
these treatments as viable options. The clinical effectiveness and
the relative cost-effectiveness of the commonly used therapies for
which there is some evidence of effect need to be researched fur-
ther. The results of the studies included in this review suggest that
non-invasive physical treatments pose little risk of serious adverse
effects. However, future studies should make a concerted effort to
systematically document side effects and ensure that they are com-
prehensively reported. In particular, there is a need to compare
long-term effects of non-invasive physical treatments with the ef-
fects of first-line efficacious medications in the prophylactic man-
agement of the different types of chronic/recurrent headaches. It is
recommended that future trials follow specific guidelines concern-
ing inclusion/exclusion criteria, classification of headaches, and
outcome measurements for headache trials (IHS 1995; IHS 2000)
so that trial results may be pooled. Future trials should also follow
the updated CONSORT statement on reporting in scientific jour-
nals (Moher 2001), which would help ensure the reliability and
validity of quality assessments. To better inform decisions about
patient management, trials should include not only evaluation of
the differences between group means, but also assessment of the
distribution of outcomes within each treatment group.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Ahonen 1984
Methods Design: parallel, 2 groups. Baseline: 2 weeks. Treatment: 3 weeks. Post-treatment follow up: 8 and 20
weeks. Randomization method: Not described. Jadad quality score: 1/5. Internal validity score: 40/100
Participants Myogenic headache associated with tension-neck syndrome (n = 22) Inclusion: chronic persistent
headache. Recruitment: patients admitted to neurological outpatient unit. Location: university hospital,
Finland. % Female: 82. Mean age: 42 years. Mean length of HA history: 6 years
Interventions G1 (n = 12): acupuncture using Shuai-ku, Feng-chih, T’ien-chu, Feng-men, Hsin-yu, Chuan-his, and
2 pressure points in neck. No report whether De Chi achieved. 4 sessions, over 3 weeks. G2 (n = 10) 3
sessions parafango (warm paraffin and mud), plus massage, then 5 sessions of massage and ultrasound
over ergonomic advice. Total of 8 sessions over 3 weeks
Outcomes Headache pain measured with VAS (0-100) during each week of baseline and treatment, and then at 8
and 20 weeks post-treatment
Headache pain intensity: At the end of 3 weeks of treatment, G2 was more favorable than G1 (G1 = 33.0
[38.1]; G2 = 29.0 [28.5] [NS). At 8 weeks post-treatment, mean headache pain intensity was lower in G2
than in G1 (G1 = 47.0 [31.2]; G2 = 30.0 [25.3] [NS]). At 20 weeks post-treatment, G1 was lower than
G2 (G1 = 28.0 [31.2]; G2 = 33.0 [28.5] [NS])
Notes Loss to follow up: not specified. Side effects: not specified
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear D - Not used
Ammer 1990
Methods Design: parallel, 3 groups. Baseline: immediately before treatment. Treatment: 2 weeks. Post-treatment
follow up: at end of treatment. Randomization method: not described. Jadad quality score: 1/5. Internal
validity score: 50/100
Participants Cervicogenic-like occipital headache (predating IHS criteria) (n = 45). Inclusion: HA </= 4 months.
Presence of blocked neck motion and trigger points. Recruitment: ambulatory patients in clinic. Location:
research outpatient clinic in Austria. % Female: 65. Median age: 52 years. Age range: 23-78. Mean weeks
since onset: 3
Interventions G1 (n = 15): spinal manipulative therapy + pulsed galvanic current to neck for 2 weeks (10 sessions). G2
(n = 15): direct galvanic current to forehead/neck plus ultrasound and UV-light over neck muscles for
2 weeks (10 sessions). G3 (n = 15): Moist herbal pack + massage of neck and shoulders for 2 weeks (10
sessions)
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Ammer 1990 (Continued)
Outcomes Main outcomes: patient-rated headache improvement (1-4). Pain scores and number of trigger points
assessed by examiners
Headache improvement: At the end of 2 weeks of treatment, scores were similar for all three groups (G1
= 1.9 [0.9]; G2 = 2.2 [0.9]; G3 = 2.3 [0.8] [NS])
Notes Loss to follow up: 7/45 (16%). Five patients in G1 and 2 in G2 discontinued treatment after 5 sessions
because they were symptom-free. Side effects: not specified
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Bitterli 1977
Methods Design: parallel, 3 groups. Baseline: prior to treatment. Treatment: 3 weeks. Post-treatment follow up: 3
months. Randomization method: drawing a lot. Jadad quality score: 2/5. Internal validity score: 29/100
Participants Cervicogenic-like headache (predating IHS criteria) (n = 30). Inclusion: Primary complaint of cervico-
genic headache, several months’ duration. Recruitment: patients attending neurological outpatient clinic.
Location: neurological outpatient clinic, Switzerland. Mean age: 31 years. Age range: 16-23. % Female:
80
Interventions G1 (n = 10): spinal manipulative therapy for 3 weeks (3.8 sessions). G2 (n = 10): mobilization for 3 weeks
(3.2 sessions). G3 (n = 10): 3-week waiting list, then spinal manipulative therapy for 3 weeks
Outcomes Average headache pain intensity measured on 100-mm VAS.
Headache pain intensity: At the end of the 3-week treatment period, G1 was more favorable than G2 and
G3 (G1 = 27.8 [30.4]; G2 = 39.5 [23.6]; G3 = 43.5 [25.4] [NS]). At 12 weeks post-treatment, G1 and
G2 were similar (G1 = 35.7 [38.4]; G2 = 32.5 [18.0] [NS])
Notes Loss to follow up: 7/30 (23%) missing pain ratings at 3 months post-treatment (G1 3/10, G2 2/10, G3
2/10). Side effects: not specified
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Boline 1995
Methods Design: parallel, 2 groups. Baseline: 2 weeks. Treatment: 6 weeks. Post-treatment follow up: 4 weeks. Ran-
domization method: 1:1 computer-generated list and sealed envelopes. Jadad quality score: 3/5. Internal
validity score: 91/100
Participants Tension-type headache (TTH). Mix of mostly chronic but also episodic TTH (n = 150). Inclusion:
Headache episode >/= 1/week for >/= 3 months, age 18-70, migraine was allowed if TTH was the
predominant headache type. Recruitment: media advertising. Location: outpatient chiropractic research
clinic in Minnesota, USA. Mean age: 42 years. Age range: 18 to 69. % Female: 62. Years since onset: 14
(mean). Number of headache episodes per week: 12 (mean)
Interventions G1 (n = 75): high-velocity, low-amplitude spinal manipulative therapy. Two 20-minute sessions per week
for 6 weeks preceded by 5-10 minutes of moist heat + 2 minutes of light massage to neck. G2 (n = 75):
amitriptyline therapy. 10 mg per day in first week, 20 mg per day in second week and 30 mg per day each
week thereafter. Patients were required to take the amitriptyline 80% of the days to be included in the
analysis. Patients in both groups were allowed to use over-the-counter pain medication on an as- needed
basis throughout the study
Outcomes Patient diaries (filled in 4x/day during 12 weeks of study) rated headache pain intensity (0-20), frequency
(no. of HAs/week), and OTC medication use (no. of pills per day). SF-36 functional status was measured
at baseline and at post-treatment follow-up. All outcomes results were adjusted for baseline differences
Headache pain intensity: During the 6-week treatment period, G2 was superior to G1 (G1 = 4.3; G2 =
3.2; difference = 1.1 [95% CI 0.2 to 2.0]). However, during the 4-week post-treatment period, G1 was
superior to G2 (G1 = 3.8; G2 = 5.2; difference = 1.4 [95% CI 0.5 to 2.3])
Headache frequency: During the 6-week treatment period, G2 was more favorable than G1 (G1 = 8.6;
G2 = 6.8; difference = 1.9 [95% CI -0.4 to 4.3). However, during the 4-week post-treatment period, G1
was superior to G2 (G1 = 7.6; G2 = 11.8; difference = 4.2 [95% CI 1.9 to 6.5])
Medication use: During the 6-week treatment period, G2 was more favorable than G1 (G1 = 1.4; G2 =
1.1; difference = 0.3 [95% CI -0.3 to 0.9]). During the 4-week post-treatment period, G1 was superior
to G2 (G1 = 1.3; G2 = 2.2; difference = 0.9 [95% CI 0.3 to 1.5])
Notes Loss to follow-up: 24/150 (16%). A best-/worst-case analysis did not change the results. Side effects: In
G1 4% reported side effects in the form of neck soreness and stiffness after treatment. In G2 82% reported
side effects, including dry mouth, drowsiness, or weight gain
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Bove 1998
Methods Design: parallel, 2 groups. Baseline: 2 weeks. Treatment: 4 weeks. Post-treatment follow-up: 13 weeks.
Randomization method: blinded drawing of ticket/lot. Jadad quality score: 3/5. Internal validity score:
58/100
Participants Episodic tension-type headache (n = 75). Inclusion: Headache episode = 5 but fewer than 15 per month.
Age range: 20-60. Typical headache intensity 25-85/100. Recruitment: newspaper advertising. Location:
outpatient chiropractic research clinic, Denmark. Mean age: 38 years. Age range: 20-59. % Female: 65
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Bove 1998 (Continued)
Interventions G1 (n = 38): soft-tissue therapy and high-velocity, low-amplitude cervical spinal manipulative therapy.
Eight 15-minute sessions were given over 4 weeks. The soft-tissue treatment consisted of deep friction
massage (including trigger point therapy if indicated) of the superficial and deep muscles of the neck
and shoulder girdle. G2 (n = 37): soft-tissue therapy as described above plus low power (placebo) laser
treatment. Eight 15-minute sessions were given over 4 weeks
Outcomes The main outcome measures were number of headache hours/day, mean headache intensity per headache
episode (0 to 100-mm VAS), and medication use
Headache pain intensity: There were relatively small differences between the two groups 1 week after 4
weeks of treatment (G1 = 38.0; G2 = 34.0), and during the 13-week post-treatment follow-up period
(G1 = 35.0; G2 = 26.0)
Headache duration: There were relatively small differences between the two groups 1 week after 4 weeks
of treatment (G1 = 1.5; G2 = 1.9), and during the 13-week post-treatment follow-up period (G1 = 2.1;
G2 = 2.2)
Medication use: There were relatively small differences between the two groups 1 week after 4 weeks of
treatment (G1 = 0.4; G2 = 0.6), and during the 13-week post-treatment follow-up period (G1 = 0.5; G2
= 0.6)
Notes Loss to follow-up: 5/75 (7%). Side effects: not specified.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Carlsson 1990
Methods Design: parallel, 2 groups. Baseline: 3 to 8 weeks. Treatment: 2 to 12 weeks. Post-treatment follow-up:
4 to 9 weeks and 7 to 12 months. Randomization method: sealed envelope. Jadad quality score: 3/5.
Internal validity score: 21/100
Participants Tension headache (study predated IHS criteria) (n = 48). Inclusion: NIH criteria. Recruitment: from
outpatient neurology and neurosurgery clinics at hospital. Location: Goteborg, Sweden. Mean age: 35
years. Age range: 18-60. % Female: 100
Interventions G1 (26): relaxation, automassage, cryotherapy, TENS, and stretching, and education regarding causative
factors and control of these factors. 10-12 sessions given over 8-12 weeks. G2 (22): classical Chinese
acupuncture points (GB 20, GB 21, LI 4), De Chi achieved. 4-10 sessions over 2-8 weeks
Outcomes Headache intensity (1-5 scale and 0 to 100-mm VAS) at baseline and 4-9 weeks post-treatment follow
up. 0 to 100-mm VAS also measured at 7 to 12 months post-treatment. Improvement of headache
intensity persisted unchanged 7-12 months after treatment. Headache frequency (1-5 scale) at baseline
and 4-9 weeks post-treatment. Between-group statistical tests not performed. Analyses based on change
in outcomes from baseline to 4-9 weeks post-treatment
Headache pain intensity: At 4-9 weeks post-treatment, G1 was superior to G2 (G1 = -1.2 [0.9]; G2 = -
0.5 [1.0] [SS])
Headache frequency: At 4-9 weeks post-treatment, G2 was more favorable than G1 (G1 = 3.7 [0.8]; G2
26Non-invasive physical treatments for chronic/recurrent headache (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Carlsson 1990 (Continued)
= 3.6 [1.1] [NS])
Notes Loss to follow up: 10/62 (16%), 4 from G1, and 6 from G2. Side effects: a few patients reported a slight
vasovagal reaction with first acupuncture treatment
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Howe 1983
Methods Design: parallel, 2 groups. Baseline: prior to treatment. Treatment: number not specified. Post-treatment
follow up: after first treatment and then 1 and 3 weeks later. Randomization method: sealed envelopes.
Jadad quality score: 2/5. Internal validity score: 25/100
Participants Subgroup of 52 neck pain patients who presented with neck-related, chronic, non-specified headache
(n = 27). Inclusion: Pain in the neck, arm, or hand due to cervical spine lesion, 50% had headaches.
Recruitment: patients routinely attending surgery. Location: two-person general practice in the UK. Mean
age: not specified. Age range: 15-65. % Female: not specified
Interventions G1 (n = 14): NSAID (azapropazone) + high-velocity, low-amplitude cervical spinal manipulative therapy.
Majority of patients received 1-2 treatments. G2 (n = 13): NSAID (azapropazone). Dosage and time not
reported
Outcomes Patient-rated degree of improvement (absent, same, better, or worse). This measure was transformed into
a percentage of patients reporting being improved
Headache improvement: Immediately after the first treatment, G1 was more favorable than G2 (G1 =
29%; G2 = 15% [p-value = 0.13]). At the end of 1 week of treatment, results were similar (G1 = 64%;
G2 = 58% [p-value = 0.87]). At the end of 3 weeks of treatment, G2 was more favorable than G1 (G1 =
92%; G2 = 100% [p-value = 0.45])
Notes Loss to follow up: not specified. Side effects: no information given
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Hoyt 1979
Methods Design: parallel, 3 groups. Baseline: immediately before treatment. Treatment: 1 session. Post-treatment
follow up: immediately after treatment. Randomization method: not reported. Jadad quality score: 1/5.
Internal validity score: 44/100
Participants Chronic muscle tension headache (predating IHS criteria) (n = 22). Inclusion: dull, non-throbbing,
bilateral headaches recurring over months or years with posterior neck discomfort. Recruitment: not
specified. Location: not specified. Mean age: not specified. Age range: not specified. % Female: not specified
Interventions G1 (n = 10): palpatory examination of cervical spine + high-velocity, low-amplitude cervical manipulation
+ soft-tissue procedures. One 10-minute session. G2 (n = 6): palpatory examination of cervical spine
without manipulation. One session. G3 (n = 6): rest supine for 10 minutes, one session
Outcomes Patient-rated headache pain intensity (0-7 scale) immediately pre- and post-treatment
Headache pain intensity: Immediately after one treatment, G1 was superior to G2 and G3 (G1 = 1.9; G2
= 0.0; G3 = 0.0 [F-value = 17.2; p < 0.0001])
Notes Loss to follow up: not specified. Side effects: No information given
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Jensen 1990
Methods Design: parallel, 2 groups. Baseline period: 5 weeks. Treatment period: 2 weeks. Post-treatment follow up
period: 3 weeks. Randomization method: envelopes. Jadad quality Score: 3/5. Internal validity score: 46/
100
Participants Post-traumatic headache (n = 23). Inclusion: post-traumatic headache symptoms 9-12 months after diag-
nosis of concussion. Recruitment: patients who had been diagnosed with concussion/suspected concussion
were contacted by telephone; those with post-traumatic headache were invited to participate. Location:
County hospital, Aarhus, Denmark. Mean age: 32 years (based on the 19 who completed the study). Age
range: 18-60. % Female: 63 (based on the 19 who completed the study)
Interventions G1 (n = 11): manual therapy to cervical and upper thoracic spine. Included specific mobilization (’soft
passive movements of joint at outer range of motion’) ’often’ in combination with muscle energy technique.
2 sessions (1/week). G2 (n = 12): Cold pack to neck and shoulders for 15-20 minutes. 2 sessions (1/week)
Outcomes Patient diaries recorded headache pain index (based on headache intensity [VAS] 4x/day for 7 days).
Analysis based on change in outcomes from baseline (weeks 1 and 5 of baseline period) to week 1 of
treatment, and weeks 1, 2, and 7 post-treatment
Headache pain intensity: At 3 weeks post-treatment, G1 was superior to G2 (G1 = -305.7 [329.5]; G2 =
67.4 [362.4] [SS]). At 8 weeks post-treatment, G1 was more favorable than G2 (G1 = -87.6 [404.8]; G2
= 53.4 [370.5] [NS])
Notes Loss to follow-up: 4/23 (17%). Side effects: not specified.
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Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Jull 2002
Methods Design: multi-center, 2x2 factorial. Baseline: 2 weeks. Treatment: 6 weeks. Post-treatment follow up: 1
week, 3, 6 and 12 months. Randomization method: permuted block, with strata for length of headache
history and city of residence. Jadad quality score: 3/5. Internal validity score: 75/100
Participants Cervicogenic headache (n = 200). Inclusion: Headache >/= 1/week duration 2 months-10 years. Recruit-
ment: referral from GP, advertisements. Location: 5 centers located in capital cities in Australia. Mean
age: 37 years. Age range: 18-60. % Female: 70
Interventions G1 (n = 51): manipulative therapy as described by Maitland, including low-velocity joint mobilization
and high-velocity, low-amplitude manipulation of cervical spine. 8-12 sessions. G2 (n = 52): therapeutic
exercise including low-load endurance exercises to train muscle control of cervical-scapular region, postural
correction exercises, cervical isometric exercises with rotary resistance, and muscle lengthening exercises
as needed. 8-12 sessions. G3 (n = 49): G1 + G2. 8-12 sessions. G4 (n = 48): Control group; no physical
treatment intervention
Outcomes Headache intensity (VAS 0-10), headache frequency (no. of HA days/week), and headache duration (no.
of hours/HA/week). Analyses based on change in outcomes from baseline to 1 week post-treatment
Headache pain intensity: G1, G2, and G3 were superior to G4 at 1 week post-treatment (G1 = 3.0 [2.2];
G2 = 3.3 [2.7]; G3 = 3.4 [2.7]; G4 = 1.4 [2.0]) and at 12 months post-treatment (G1 = 2.3 [2.6]; G2 =
2.8 [2.6]; G3 = 2.7 [2.2]; G4 = 1.3 [2.4])
Headache frequency: G1, G2, and G3 were superior to G4 at 1 week post-treatment (G1 = 2.1 [2.0]; G2
= 2.4 [1.5]; G3 = 2.0 [1.7]; G4 = 0.8 [1.7]) and at 12 months post-treatment (G1 = 2.3 [1.9]; G2 = 2.5
[1.7]; G3 = 2.1 [1.6]; G4 = 1.0 [1.6])
Headache duration: G3 was superior to G4 at 1 week post-treatment (G1 = 3.5 [3.9]; G2 = 2.2 [3.6];
G3 = 4.3 [4.4]; G4 = 2.1 [3.7]) and 12 months post-treatment (G1 = 3.0 [4.9]; G2 = 2.4 [4.6]; G3 = 4.3
[4.6]; G4 = 2.0 [4.4])
Notes Loss to follow up: 7/200 (3.5%). Side effects: 6.7% of headaches experienced by patients during treatment
period (group not specified) were reportedly provoked by treatment
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
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Keller 1986
Methods Design: parallel, 2 groups. Baseline: immediately prior to treatment. Treatment: 5 minutes. Post-treatment
follow up: 5 minutes and 4 hours post-treatment. Randomization method: random number table. Jadad
quality score: 3/5. Internal validity score: 50/100
Participants Tension headache (n = 60). Inclusion: Dull persistent head pain, usually bilateral, with feelings of heaviness,
pressure or tightness; no headache medication within 4 hours prior to study entry. Recruitment: 1)
university student clinic, 2) university student and staff population, and 3) radio, newspaper and bulletin
board advertisements in general population. Location: US. Mean age: 30 years. Age range: 18-59. %
Female: 75
Interventions G1 (n = 30): Therapeutic touch with intention to heal plus rest and deep breathing; 1 session. G2 (n =
30): Placebo touch without intention to heal plus rest and deep breathing; 1 session
Outcomes Pain using 3 subscales from McGill-Melzack Pain Questionnaire: Pain Rating Index, Number of Words
Chosen, and Present Pain Intensity (0-10) measured immediately prior to treatment, and 5 minutes and
4 hours post-treatment. Data for all patients not presented at 4 hours post-treatment follow up
Present Pain Intensity: 5 minutes after one treatment, G1 was superior to G2 (G1 = 0.76; G2 = 1.82;
difference = 1.1 [p < 0.005]). 4 hours post-treatment, G1 was again superior to G2 (G1 = 0.54; G2 =
1.40; difference = 0.9 [p-value < 0.01])
Notes Loss to follow up: Not specified. Side effects: not specified
15 subjects in G2 and 5 subjects in G1 used additional treatments for headache relief during the 4-hour
post-treatment follow-up period. When these subjects were removed from analysis, statistically significant
differences were found in favor of G1 for all three pain scales
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Marcus 1998
Methods Design: parallel, 2 groups. Baseline: 2 weeks. Treatment: 4 weeks. Post-treatment follow up: not specified.
Randomization method: not specified. Jadad quality score: 1/5. Internal validity score: 33/100
Participants Migraine headache (n = 88). Inclusion: Migraine headache +/- aura using IHS classification, >/= 1/week
or >/= 5 days/month. Recruitment: newspaper advertisement, posters. Location: US. Mean age: 37 years.
Age range: 20-58. % Female: 100
Interventions G1 (n = 43): postural correction, cervical range-of-motion exercises, isometric neck strengthening exercises,
self-mobilization exercises, whole body stretching and conditioning, and ’flare up’ management techniques
(heat, ice, distraction, oscillatory movements, trigger point treatment). Patients instructed to perform
program 2x/day. Four weekly 1-hour treatment sessions. G2 (n = 45): progressive muscle relaxation,
breathing exercises, and thermal biofeedback training. Patients instructed to perform program 2x/day.
Four weekly 1-hour treatment sessions
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Marcus 1998 (Continued)
Outcomes Patient diaries at baseline and post-treatment recorded daily headache severity and medication use (severity
rated 4x/day). A headache index (HI) score was calculated by taking the mean headache severity score over
2 weeks. >/= 50% reduction in HI considered clinically important. Subjects achieving >/= 50% reduction
in HI scores were followed up at 3, 6, and 12 months. Treatment success maintained in both groups;
however, no between-group analysis done. HI analyses based on change in outcome from baseline to after
4 weeks of treatment
Headache index: After 4 weeks of treatment, G2 was superior to G1 (G1 = -0.4; G2 = -1.0 [p < 0.01]).
Proportion 50% improved: After 4 weeks of treatment, G2 was superior to G1 (G1 = 13%; G2 = 51%
[p < 0.001])
Notes Loss to follow up: 19/88 (22%). 13 in G1 (10 did not start treatment) and 6 in G2 (5 did not start
treatment). Side effects: not specified
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Nelson 1998
Methods Design: parallel, 3 groups. Baseline: 4 weeks. Treatment: 8 weeks. Post-treatment follow-up: 4 weeks.
Randomization method: computer-generated 1:1:1 allocation, sealed opaque envelopes. Jadad quality
score: 3/5. Internal validity score: 91/100
Participants Chronic migraine headache (n = 218). Inclusion: </= 4 episodes/month, duration </= 1 year. Recruitment
by newspaper advertising to outpatient chiropractic research clinic in Minnesota, USA. Mean age: 38
years. Age range: 18-65. % Female: 79. 87% of all patients had more than 5 years’ duration of migraine
Interventions G1 (n = 77): high-velocity, low-amplitude cervical spinal manipulation. 14 sessions. Each session started
with 5-10 minutes of light massage +/- trigger point therapy. G2 (n = 70): amitriptyline therapy. The
dosage of 25 mg/day for the first week was increased to 50 mg/day the next week and to 75 mg/day the
next week, ending with a maximum of 100 mg/day after 3 weeks. G3 (n = 71): G1 + G2
Outcomes Main outcome: headache index = pain intensity (0-10)/day x 7 (0-70) during 4-week baseline, last 4 weeks
of treatment, and during the 4-week follow up. Secondary outcomes were OTC medication use at all time
points, and SF-36 functional status measured at baseline and at post-treatment follow up. All outcome
results were adjusted for baseline differences in the analysis
Headache index: During the last 4 weeks of the treatment, scores were similar in all 3 groups, although
slightly more favorable in G1, (G1 = 9.8 [6.3]; G2 = 9.1 [6.3]; G3 = 9.8 [6.3]). At 4 weeks post-treatment,
G1 was superior to G2, and G3 (SS) (G1 = 9.8 [7.0], G2 = 12.6 [7.0]; G3 = 12.6 [7.0]).
Medication use: During the last 4 weeks of treatment, scores were similar among groups, but slightly more
favorable in G2 (G1 = 1.1 [1.1]; G2 = 0.9 [1.0]; G3 = 1.1 [1.1]). At 4 weeks post-treatment, G1 was
superior to G3 (SS) (G1 = 1.1 [1.3], G2 = 1.4 [1.3]; G3 = 1.7 [1.5])
Notes Loss to follow-up: 56/218 (26%). Alternative analysis with imputed data based on a missing data analysis
did not change the trial results and conclusions. Side effects: 58% of patients in G2 and G3 reported
side effects including dry mouth, drowsiness, or weight gain; 10% withdrew from treatment due to side
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Nelson 1998 (Continued)
effects. Side effects for G1 were infrequent and mild (neck soreness). No patients withdrew due to side
effects
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Nilsson 1997
Methods Design: prospective, parallel, 2 groups. Baseline: 1-2 weeks. Treatment: 3 weeks. Post-treatment follow
up: 1 week. Randomization method: labeled tickets prepared in advance, randomly drawn by project
secretary. Jadad quality score: 3/5. Internal validity score: 65/100
Participants Cervicogenic headache (n = 54). Inclusion: Headache >/= 5 days/month, duration >/= 3 months, no
effect of migraine medication, no prior spinal manipulation, headache located in occipital region with or
without forward radiation, patient able to identify neck movements or postures that aggravate headaches,
decreased passive range of motion of cervical spine, typical headache intensity 25-85/100. Recruitment:
advertisements in local press. Location: outpatient clinic, Denmark. Median age: 37 years. Age range: 20-
60. % Female: 57
Interventions G1 (n = 28): high-velocity, low-amplitude spinal manipulation; toggle recoil technique in upper cervical
spine, diversified technique in lower cervical spine. 6 sessions. G2 (n = 26): deep friction massage including
trigger point therapy to the posterior muscles of shoulder girdle and upper thoracic and lower cervical
region plus low-level laser (no therapeutic effect). 6 sessions
Outcomes Patient diaries recorded headache episode intensity (0-100 VAS), number of headache hours/day, and
number of pain killers/day during 1-week baseline period and 1 week post-treatment follow-up period.
Analyses based on change in outcomes from baseline to post-treatment follow up
Headache pain intensity: At the end of 4 weeks of treatment, G1 was superior to G2 (G1 = 17.0; G2 =
4.2; difference = 12.8 [p = 0.04])
Medication use: At the end of 4 weeks of treatment, G1 was more favorable than G2 (G1 = 0.7; G2 =
0.3; difference = 0.4 [p = 0.14])
Headache duration: At the end of 4 weeks of treatment, G1 was superior to G2 (G1 = 3.2; G2 = 1.6;
difference = 1.6 [p = 0.03])
Notes Loss to follow-up: 1/54 (2%). Side effects: None reported. Special note: 15/54 participants were enrolled
at a later date (after some statistical analyses had been performed) and had 1 week of baseline instead of
2 weeks
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Parker 1980
Methods Design: prospective, parallel, 3 groups. Baseline: 2 months. Treatment: 2 months. Post-treatment follow
up: 2 months. Randomization method: not specified. Jadad quality score: 1/5. Internal validity score: 67/
100
Participants Migraine headache (n = 85). Inclusion: Diagnosis of migraine headache (predates IHS criteria). Recruit-
ment: media. Location: Australia. Mean age: 41 years. Age range: 12-55. % Female: 61
Interventions G1 (n = 30): cervical spine manipulation (’movement of joint beyond normal limitations’) + other spinal
manipulation, all provided by chiropractors. Up to 2 sessions per week. G2 (n = 27): cervical spine
manipulation + other ’manipulatory techniques’, all provided by medical doctors or physical therapists.
Up to 2 sessions per week. G3 (n = 28): cervical spine mobilization (’small oscillatory movements to a
joint within its normal range’) + other spinal mobilization, all provided by medical doctors or physical
therapists. Up to 2 sessions per week
Outcomes Patient diaries (’migraine form’) filled out after each migraine attack recording headache frequency,
headache duration (hours/attack), headache intensity (VAS 0-10); disability (1-5). Analyses based on
group differences in change scores in outcomes from baseline to post-treatment follow up
Outcomes at 8 weeks post-treatment:
Headache intensity: G1 = 2.1; G2 = 0.6; G3 = 0.7
(group differences NS).
Headache frequency: G1 = 3.5; G2 = 1.2; G3 = 3.0 (group differences NS)
Headache duration: G1 = 5.1; G2 = 0.1; G3 = 3.0 (group differences NS)
Headache disability: G1 = 0.9; G2 = 0.3; G3 = 0.6
(group differences NS).
Notes Loss to follow up: 3/85 (4%). Side effects: not specified.
In the trial, several contrasts were made and F-ratios were given: G1 vs. G2 + G3, and G1 + G2 vs. G3.
The means for the group combinations were not reported
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Reich 1989
Methods Study design: parallel, 4 groups. Baseline: 4 weeks. Treatment: ?. Post-treatment follow up: 1, 8, 24, and
36 months. Randomization method: not specified. Jadad quality score: 0/5. Internal validity score: 29/
100
Participants Vascular/migraine and muscle contraction headache (n = 703 uncertain). Inclusion: Either vascular or
muscle contraction headache (could not have both). Recruitment: physician referral. Location: US. Mean
age: not specified. Age min: 18. % Female: 58 (of the 703 who completed study)
Interventions G1 (n = 173) relaxation, including cognitively oriented psychotherapy, hypnosis, or progressive muscle
relaxation. G2 (n = 161): electrical modalities, including TENS and electrical neurotransmitter modula-
tion. G3 (n = 178): biofeedback (thermal or EMG). G4 (n = 191): multi-modal group (a combination
of two of the above groups). Each group received either </= 15 treatment sessions, or >/= 15 treatment
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Reich 1989 (Continued)
sessions
Outcomes Patient diaries recorded daily headache pain (1-5) measured 6x/day, and medication use. Diaries kept for
4-week periods at baseline, immediately following treatment, eight months, 24 months, and 36 months.
Analysis stratified by number of treatments (</= 15 and > 15) and type of headache (migraine or tension-
type). Results presented in graphs and difficult to interpret. Repeated measures analyses found statistically
significant results between groups for pain and weekly headache hours. Combination of treatments in G4
not specified. No means or variability estimates were given; means estimated from graphs
Headache pain intensity (migraine): G1 performed the worst and G3 performed the best at the end of 4
weeks of treatment (G1 = 2.7; G2 = 2.0; G3 = 1.4), and 36 months post-treatment (G1 = 3.0; G2 = 2.4;
G3 = 1.8)
Headache duration (migraine): G1 performed the worst and G3 performed the best at the end of 4 weeks
of treatment (G1 = 8.0; G2 = 3.5; G3 = 1.0), and 36 months post-treatment (G1 = 13.0; G2 = 7.0; G3
= 1.5)
Headache pain intensity (tension-type): G1 performed the worst and G3 performed the best at the end
of 4 weeks of treatment (G1 = 2.5; G2 = 2.2; G3 = 1.8), and 36 months post-treatment (G1 = 2.9; G2 =
2.3; G3 = 1.7)
Headache duration (tension-type): G1 performed the worst and G3 performed the best at the end of 4
weeks of treatment (G1 = 10.0; G2 = 5.0; G3 = 1.0), and 36 months post-treatment (G1 = 15.0; G2 =
8.0; G3 = 1.5)
Notes Loss to follow up: not specified.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Sherman 1998
Methods Design: 2 groups, double-blind crossover. Baseline: 3-6 weeks. Treatment: 2 weeks then crossed over to
other group for 2 weeks. Post-treatment follow up: 3 weeks and 1-6 months. Randomization method:
sealed envelope. Jadad quality score: 3/5. Internal validity score: 50/100
Participants Migraine (n = 12). Inclusion: Migraine headaches as defined by IHS, multi-year history of headache.
Recruitment: from patients at military center. Location: US Army Medical Center. Mean age: 50. Age
range: 33-63. % Female: 83
Interventions G1 (n = 7): pulsating electromagnetic field (PEMF) applied to medial thigh. 10 sessions (1 hour/day, 5
days/week). G2 (n = 5): placebo (inactive PEMF). 10 sessions (1 hour/day, 5 days/week). Note: G1 and
G2 represent patients who received that treatment first, prior to crossing over to other treatment
Outcomes Patient diaries recorded number of headaches per week measured during baseline and 2-week treatment
period. Analyses based on change in outcomes from baseline to after 2 weeks of treatment
Number of headaches/week: After 2 weeks of treatment, G1 was less favorable than G2 (G1 = 2.3 [1.5];
G2 = 0.8 [0.9] [NS])
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Notes Three patients in G1 inadvertently received half power treatments. Side effects: not specified
Data are presented for the patients who received either treatment first, as 5/6 patients (active PEMF first)
declined to cross over
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Sherman 1999
Methods Design: prospective, parallel, 2 groups. Baseline: 1 month. Treatment: 2 weeks. Post-treatment follow
up: 1 month. Randomization method: computer-generated algorithm. Jadad quality score: 4/5. Internal
validity score: 39/100
Participants Migraine (n = 48). Inclusion: Migraine headaches as defined by IHS. Recruitment: not specified. Location:
not specified. Mean age: 46 years. Age range: not specified. % Female: 81 (based on the 42 individuals
who completed study)
Interventions G1 (n = 27): pulsating electromagnetic field (PEMF) applied to medial thigh. 10 sessions (1 hour/day, 5
days/week). G2 (n = 21): placebo (inactive PEMF). 10 sessions (1 hour/day, 5 days/week)
Outcomes Diaries recording headache frequency, duration, intensity (VAS 0-10), and headache-related medication
use. Composite scores indicating ’headache activity’ calculated from change in outcomes from baseline to
4 weeks post-treatment
Headache activity index: After 2 weeks of treatment, G1 was superior to G2 (G1 = 3.5 [1.0]; G2 = 2.6
[1.0] [SS])
Notes Loss to follow up: 6/48 (13%). Three were dropouts (2 active treatment group, 1 placebo group) and
3 patients experienced only tension-type headaches during study and were removed from analyses. Side
effects: not specified
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Solomon 1985
Methods Design: parallel, 3 groups. Baseline: immediately pre-treatment. Treatment: one session. Post-treatment
follow up: immediately post-treatment. Randomization method: not described. Jadad quality score: 0/5.
Internal validity score: 19/100
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Participants Migraine (22/62) or muscle-contraction headache (33/62) or both (8/62) (n = 62). Inclusion: not specified.
Recruitment: patients presenting to headache unit at time of headache asked to participate. Location:
headache unit of medical center, New York. Age mean/median: not specified. Age range: not specified. %
Female: not specified
Interventions G1 (n = 18): Cranial electrotherapy-perceived stimulus max at 4 milliamp. One 15-minute session. G2
(n = 18): Cranial electrotherapy-subliminal stimulus max at 4 milliamp. One 15-minute session. G3 (n
= 22): detuned cranial electrotherapy (placebo). One 15-minute session
Outcomes Patient-rated pain severity (1-10 scale) measured immediately pre- and post-treatment
Headache pain intensity improvement: Immediately after one treatment, G1 was superior to G3 (G1 =
2.1 [1.9]; G2 = 1.0 [1.5]; G3 = 0.9 [1.5])
Notes Loss to follow up: 4/62 (6%) due to ’technical reasons’. Side effects: no information given
Raw data were extracted from tables to calculate change scores from baseline to post-treatment. Standard
deviations on the change scores were then calculated
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Solomon 1989
Methods Design: parallel, 2 groups, double-blind, placebo-controlled. Baseline: before each treatment. Treatment:
6-10 weeks (minimum of 4 episodes of headache). Post-treatment follow up: after each treatment and at
end of 6- to 10-week treatment period. Randomization method: not described. Jadad quality score: 1/5.
Internal validity score: 42/100
Participants Muscle contraction headache (n = 112). Inclusion: Tension-type headache with or without migraine
headache, 4 episodes/month for 1 year. Age > 18. Recruitment: from private practice or clinic practices.
Location: Multi-center, US. Age mean/median: mean of 42 years. Age range: 20-70. % Female: not
specified
Interventions G1 (n = 57): cranial electrotherapy (CE), given at max tolerance (1-4 milliamps). Automatic shut off
after 20 minutes. G2 (n = 55): placebo CE. Automatic shut-off after 70 seconds, but meter registered 1-4
milliamps for 20 minutes. All patients instructed in use of pain suppressor unit at home when experiencing
a headache episode. Each session lasted 20 minutes. If necessary a second 20-minute session was allowed
Outcomes Patient diaries rated pain intensity (0-10 scale) before and after use of stimulator unit. Global rating of
improvement at end of study on 4-level ordinal scale (highly to not effective). Headache pain intensity
analysis based on change in outcome from baseline to the end of 4-6 weeks of treatment
Headache pain intensity: At the end of 4-6 weeks of treatment, G1 was superior to G2 (G1 = 2.1 [2.1];
G2 = 1.2 [2.1] [SS])
% of patients rating CE effective: At the end of 4-6 weeks of treatment, G1 was superior to G2 (G1 =
36%; G2 = 16% [p = 0.006])
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Solomon 1989 (Continued)
Notes Loss to follow up: 12/112 (11%) because of lack of headaches that could be evaluated. Side effects: 6/57
in G1 (active) and 7/55 in G2 (placebo) noted side effects (e.g. nausea, dizziness, rash). For G1 the most
common symptom was irritation at the electrode sites. G1 had longer duration in hours of headaches at
baseline than G2
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Tuchin 2000
Methods Design: Prospective, parallel, 2 groups. Baseline: 2 months. Treatment: 2 months. Post-treatment follow
up: 2 months. Randomization method: participants were ’randomly allocated’ based on the first letter of
the participant’s surname by an ’impartial research assistant’. Jadad quality score: 1/5. Internal validity
score: 38/100
Participants Migraine (n = 127). Inclusion: Headache >/= 1x/month. Had to have >/= 5 of the following: 1) inability
to continue normal activities or need to seek quiet, dark area, 2) pain in temples, 3) throbbing pain, 4)
nausea, vomiting, aura, photophobia or phonophobia, 5) migraine precipitated by weather changes, 6)
migraine aggravated by head or neck movements, 7) previous diagnosis of migraine by specialist, 8) family
history of migraine. Recruitment: radio and newspaper advertisements. Location: chiropractic research
center, Macquarie University, Sydney, Australia. Mean age: 39 years. Age range: not specified. % Female:
68
Interventions G1 (n = 83): high-velocity, low-amplitude spinal manipulative therapy; area of spine not specified. Up to
16 treatments. G2 (n = 40): detuned interferential therapy. Number of sessions unspecified
Outcomes Patient diaries recorded intensity (VAS 0-10 scale), headache frequency (no. episodes/month), duration
(no. of hours per episode), and disability (no. of hours before able to return to normal activities) for 6-
month study period. Analyses based on change in outcomes from baseline to post-treatment period
Headache pain intensity: At 8 weeks post-treatment, G2 was more favorable than G1 (G1 = 1.1; G2 =
1.7 [p > 0.05])
Headache duration: At 8 weeks post-treatment, G1 was superior to G2 (G1 = 8.5; G2 = 2.8 [p < 0.01])
Headache frequency: At 8 weeks post-treatment, G1 was superior to G2 (G1 = 3.0; G2 = 0.4 [p < 0.005])
Medication use: At 8 weeks post-treatment, G1 was superior to G2 (G1 = 11.5; G2 = 3.9 [p < 0.001])
Notes Loss to follow up: 4/127 (3%). Side effects: 2 patients from G1 withdrew from study due to side effects,
including soreness and increased migraine headache
Tuchin et al correctly used analysis of covariance to adjust for differences in baseline values. The change
scores from baseline and post-treatment have been abstracted and the effect sizes have been calculated
based on the change scores and the p-values
Risk of bias
Item Authors’ judgement Description
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Allocation concealment? No C - Inadequate
Whittingham 1997
Methods Design: 2 groups, blinded, placebo-controlled, crossover. Powered at 80% for first phase, parallel-group
design. Baseline: 3 weeks. Treatment: 3 weeks. Washout: 3 weeks. Crossover treatment: 3 weeks. Washout:
3 weeks. Post-treatment follow up: 8 and 12 months. Randomization method: drawing allocated file
numbers out of a hat. Jadad quality score: 3/5. Internal validity score: 54/100
Participants Cervicogenic headache (n = 105). Inclusion criteria: > 6 months’ duration, >/= 4 episodes/month. Recruit-
ment by advertising in daily newspaper, university newsletter, and radio. Location: outpatient chiropractic
research clinic in Melbourne, Australia. Mean age: 41 years. Age range: 17-81. % Female: 60. 64% had
HA duration of > 10 years
Interventions G1 (n = 56): spinal manipulative therapy (toggle recoil) to upper cervical spine. 3 sessions/week for 3
weeks. G2 (n = 49): Placebo (deactivated mechanical adjusting instrument to upper cervical spine). 3
sessions/week for 3 weeks
Outcomes Measured before and after each treatment phase: Main outcome: Pain drawing of head and neck with pain
intensity (0-100) and number of headache locations. Secondary outcomes: Neck Disability Index (NDI)
, Sickness Impact Profile (SIP), cervical spine range of motion, and pressure algometry. Patient diaries
recorded headache intensity, number and duration of episodes, and medication use
Headache pain intensity: (from pain drawings) At the end of 3 weeks of treatment, G1 was superior to
G2 (G1 = 23.9 [28.5]; G2 = 77.7 [20.1] [SS])
Headache disability (NDI subscale): At the end of 3 weeks of treatment, G1 was superior to G2 (G1 =
1.6 [1.5]; G2 = 2.9 [0.9] [SS])
Number of headache locations: At the end of 3 weeks of treatment, G1 was superior to G2 (G1 = 2.0
[2.3]; G2 = 5.6 [4.1] [SS])
Notes 3/105 (3%) lost to follow-up. Carry-over and time effects present. Trial result evaluated on outcomes from
first phase. Unexplained inconsistency between main outcomes and diary data. Effectiveness of blinding
not evaluated adequately. Side effects: None from either treatment
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
CE = cranial electrotherapy; CI = confidence interval; EMG = electromyographic; G = (treatment) group; GP = general practitioner;
HA = headache; HI = headache index; IHS = International Headache Society; NIH = National Institutes of Health; NS = not
statistically significant (p > 0.05); NSAID = non-steroidal anti-inflammatory drug; OTC = over-the-counter; PEMF = pulsating
electromagnetic field; SS = statistically significant (p </= 0.05); TENS = transcutaneous electrical nerve stimulation; TTH = tension-
type headache; UV = ultraviolet; VAS = visual analog scale
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Ahmed 2000 Intervention of interest: invasive physical treatment
Airaksinen 1992 Condition studied: change in trigger points
Gray 1994 Condition studied: change in TMJ symptoms
Iwata 1998 Condition studied: visual disturbance/symptoms
Kaliappen 1987 Intervention of interest: yoga/relaxation
Kaliappen 1992 Intervention of interest: yoga/relaxation
Karppinen 1999 Intervention of interest: invasive physical treatment
Lemstra 2002 Non-invasive treatment could not be isolated from mulitimodal intervention
MacNeil 1995 No quantitative data available. Intervention of interest: therapeutic touch
Sargent 1986 Intervention of interest: relaxation/biofeedback
Scharff 1996 Follow-up data on patients from Marcus 1998; could not be analyzed
Schokker 1990 Condition studied: change in TMJ symptoms
Sethi 1981 Intervention of interest: yoga/relaxation
Witucki 1994 Intervention of interest: aerobic exercises
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D A T A A N D A N A L Y S E S
This review has no analyses.
A D D I T I O N A L T A B L E S
Table 1. Definition of levels of evidence
Level of evidence of efficacy or
inefficacy
# RCTs with validity score >/=
50
# RCTs with validity score < 50 Notes
Strong >/= 2 - Absolute efficacy: A treatment
was superior(1) to a placebo or
no-treatment control with p <
0.05.
Relative efficacy: A treatment
was superior(1) to a com-
parison therapy with p <
0.05, or superior(1)/similar(2)/
equivalent(3) to an established
efficacious treatment with LCL
> -0.4. A combination therapy
was superior(1) to one of its
components with p < 0.05.
Absolute inefficacy: A treat-
ment was inferior(4) to a
placebo or no-treatment con-
trol with p < 0.05, or inferior
(4)/similar(2)/equivalent(3) to
a placebo or no-treatment con-
trol with UCL < 0.4.
Relative inefficacy: A treatment
was inferior(4) to a comparison
therapy with p < 0.05. A com-
bination therapy was inferior(4)
to one of its components with
p < 0.05, or inferior(4)/similar
(2)/equivalent(3) to one of its
components with UCL < 0.4
Moderate 1 - As above.
Limited - >/= 1 As above.
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Table 1. Definition of levels of evidence (Continued)
Preliminary Standards for classi-
fication above were not met for
either statistical significance or
confidence limits
Conflicting The evidence from RCTs that
could be pooled was conflicting.
Key to terms: (1) Superior: ES >/= 0.4.
(2) Similar: -0.4 < ES < 0.4.
(3) Equivalent: 0.4 > ES, LCL,
& UCL > -0.4.
(4) Inferior: ES </= -0.4.













Howe 1983 Hoyt 1979
Group com-
parability




- - p p p p p -
Outcome
measure
+ p + + + + p p
Patient
blinding








- - p p p p - p
Attention
bias
- p - na p - - p
A priori hy-
pothesis
p + p + p - - +
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- - - + + - - -
Dropouts
analysis
na na - + p p - na
Missing data
analysis




+ + - + + - + na
p-level
adjustments
+ - na + - - - na
Total valid-
ity % score





















p - - + + + - -
Confidence
intervals
p - + + + p + -
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Table 2. Methodological quality of included studies A -H (+ = yes; - = no; p = unclear) (Continued)
Appropriate
conclusions












0 0 0 0 0 0 0 0
Dropouts
analysis
1 1 0 1 1 1 0 1
Total Jadad
score
1 1 2 3 3 3 2 1
Table 3. Methodological quality of included studies J-P (+ = yes; - = no; p = unclear)
Validity items Jensen 1990 Jull 2002 Keller 1986 Marcus 1998 Nelson 1998 Nilsson 1997 Parker 1980
Group
comparability




p + p - p p -
Outcome
measure
+ + + + + + +
Patient blind-
ing








p p p p p p p
Attention bias - - p - na + +
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Table 3. Methodological quality of included studies J-P (+ = yes; - = no; p = unclear) (Continued)
A priori hy-
pothesis
p + + p + + +
Appropriate
statistical tests
+ + + - + + +
Adequate sta-
tistical power
- + - - + - -
Dropouts
analysis
p + p p + na p
Missing data
analysis
- p - - + na p
Intention-to-
treat analysis
+ + na p + + +
p-level adjust-
ments
- - - - + - +
Total validity
% score







p + p p + + +
Adequate fol-
low-up period








- + - + + + -
Confidence
intervals
+ + - - + + -
Appropriate
conclusions
p p p p + p p
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0 0 0 0 0 0 0
Dropouts
analysis
1 1 1 1 1 1 1
Total Jadad
score
3 3 3 1 3 3 1
Table 4. Methodological quality of included studies R-Z (+ = yes; - = no; p = unclear)
















- p p - - - p
Outcome
measure
+ + + p + + +
Patient blind-
ing








p - p p p p p
Attention bias - + + - na - p
A priori hy-
pothesis
p + p p p - -
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Table 4. Methodological quality of included studies R-Z (+ = yes; - = no; p = unclear) (Continued)
Appropriate
statistical tests
+ p - - + - +
Adequate sta-
tistical power
- - - - - - +
Dropouts
analysis
- na - - p + na
Missing data
analysis
- na - - - p p
Intention-to-
treat analysis
p - - p p p -
p-level adjust-
ments
- na - na - - -
Total validity
% score







p p p p p + +
Adequate fol-
low-up period








+ - p + - - +
Confidence
intervals
- p + + + + +
Appropriate
conclusions
p p p p p - +
Jadad scale
item
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0 0 2 0 0 0 0
Dropouts
analysis
0 1 0 0 1 1 1
Total Jadad
score
0 3 4 0 1 1 3






























































-0.7 -1 -0.1 -0.5 to 0.3 SMD
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Table 5. List of comparisons: migraine headache (* - sign favors comparison group) (Continued)
(As above) (As above) 4 weeks
post-
treatment











-0.2 na -0.2 -0.6 to 0.2 SMD
(As above) (As above) 4 weeks
post-
treatment














0.0 0 0.0 -0.4 to 0.4 SMD
(As above) (As above) 4 weeks
post-
treatment











0.0 na 0.0 -0.4 to 0.4 SMD
(As above) (As above) 4 weeks
post-
treatment
















-0.7 -1 -0.1 -0.5 to 0.4 SMD
(As above) (As above) 4 weeks
post-
treatment
0.0 0 0.0 -0.4 to 0.4 SMD
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-0.2 na -0.2 -0.6 to 0.2 SMD
(As above) (As above) 4 weeks
post-
treatment
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2.3 na ? ? ?
Headache
duration
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-0.6 -12 ? ? ?
As above As above 36 months
post-
treatment









-2.5 na ? ? ?
As above As above 36 months
post-
treatment
















0.7 14 ? ? ?
51Non-invasive physical treatments for chronic/recurrent headache (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 5. List of comparisons: migraine headache (* - sign favors comparison group) (Continued)
As above As above 36 months
post-
treatment









4.5 na ? ? ?
As above As above 36 months
post-
treatment





















































-0.6 -6 -0.4 -0.8 to 0.1 p-values
Headache
duration
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7.6 na 0.6 0.3 to 1.0 p-values
































373.1 na 1.1 0.1 to 2.0 SMD
(As above) (As above) 8 weeks
post-
treatment



















1.2 12 0.7 0.1 to 1.3 SMD
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0.2 2 0.1 -0.5 to 0.7 SMD



































-4.0 -4 -0.1 -1.0 to 0.8 SMD
As above As above 8 weeks
post-
treatment
-17.0 -17 -0.6 -1.5 to 0.3 SMD
As above As above 20 weeks
post-
treatment
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-1.1 -6 -0.4 -0.8 to 0.0 SMD














-1.8 -6 -0.3 -0.7 to 0.1 SMD
















-0.3 na -0.2 -0.6 to 0.2 SMD





















-4.0 -4 -0.3 -0.8 to 0.2 CIs and p-
values
(As above) (As above) 13
weeks after
4 weeks of
-9.0 -9 -0.4 -0.9 to 0.1 CIs and p-
values
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0.4 2 -0.1 -0.6 to 0.4 CIs and p-
values
















0.2 na 0.1 -0.4 to 0.6 CIs and p-
values
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1.1 18 1.1 0.5 to 1.6 p-value
(As above) (As above) 4 hours af-
ter 1 treat-
ment



















-0.4 -8 ? ? ?
As above As above 36 months
post-
treatment









-4.0 na ? ? ?
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Table 7. List of comparisons: tension-type headache (* - sign favors comparison group) (Continued)
As above As above 36 months
post-
treatment
















0.3 6 ? ? ?
As above As above 36 months
post-
treatment









5.0 na ? ? ?
As above As above 36 months
post-
treatment
































20.0 na 0.6 0.2 to 1.0 p-value
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11.7 12 0.4 -0.5 to 1.4 SMD
(As above) (As above) 12 weeks
post-
treatment










15.7 16 0.6 -0.4 to 1.5 SMD
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14.0 na 0.5 -0.5 to 1.5 Probit
transfor-
mation
(As above) (As above) End of
1 week of
treatment
6.0 na 0.1 -0.9 to 1.1 Probit
transfor-
mation
(As above) (As above) End of
3 weeks of
treatment











-0.3 -3 -0.1 -0.5 to 0.3 SMD
(As above) (As above) 1
year post-
treatment











-0.3 -4 -0.2 -0.6 to 0.2 SMD
(As above) (As above) 1
year post-
treatment
-0.3 -4 -0.1 -0.5 to 0.3 SMD
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1.3 6 0.3 -0.1 to 0.8 SMD
(As above) (As above) 1
year post-
treatment
0.7 3 0.1 -0.3 to 0.5 SMD










-0.4 -4 -0.1 -0.5 to 0.3 SMD
(As above) (As above) 1
year post-
treatment










0.1 1 0.0 -0.4 to 0.4 SMD
(As above) (As above) 1
year post-
treatment










-0.8 -3 -0.2 -0.6 to 0.2 SMD
(As above) (As above) 1
year post-
treatment
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0.1 1 0.0 -0.4 to 0.4 SMD
(As above) (As above) 1
year post-
treatment










-0.4 -5 -0.2 -0.6 to 0.2 SMD
(As above) (As above) 1
year post-
treatment










2.1 9 0.5 0.1 to 0.9 SMD
(As above) (As above) 1
year post-
treatment











1.6 16 0.7 0.3 to 1.2 SMD
(As above) (As above) 1
year post-
treatment










1.3 18 0.7 0.3 to 1.1 SMD
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Table 8. List of comparisons: cervicogenic headache (* - sign favors comparison group) (Continued)
(As above) (As above) 1
year post-
treatment










1.3 6 0.3 -0.1 to 0.8 SMD
(As above) (As above) 1
year post-
treatment













2.0 19 0.8 0.4 to 1.2 SMD
(As above) (As above) 1
year post-
treatment










1.2 18 0.7 0.3 to 1.1 SMD
(As above) (As above) 1
year post-
treatment










2.1 9 0.5 0.1 to 0.9 SMD
(As above) (As above) 1
year post-
treatment
2.3 9 0.5 0.1 to 0.9 SMD
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1.8 18 0.8 0.3 to 1.2 SMD
(As above) (As above) 1
year post-
treatment










1.6 23 1.0 0.5 to 1.4 SMD
(As above) (As above) 1
year post-
treatment










0.0 0 0.0 -0.4 to 0.4 SMD
(As above) (As above) 1
year post-
treatment























0.4 na 0.3 -0.2 to 0.8 means and
p-value
64Non-invasive physical treatments for chronic/recurrent headache (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.













































3.6 na 1.1 0.7 to 1.5 SMD
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
The full MEDLINE search strategy, which was adapted for use in the other electronic databases searched, was as follows:
1. randomized controlled trial.pt.
2. controlled clinical trial.pt.
3. randomized controlled trials.sh.
4. random allocation.sh.
5. double blind method.sh.
6. single-blind method.sh.
7. or/1-6
8. (animal not human).sh.
9. 7 not 8
10. clinical trial.pt.
11. exp clinical trials/
12. (clin$ adj25 trial$).ti,ab.






19. 18 not 8
20. 19 not 9
21. comparative study.sh.
22. exp evaluation studies/
23. follow up studies.sh.
24. prospective studies.sh.
25. (control$ or prospectiv$ or volunteer$).ti,ab.
26. or/21-25
27. 26 not 8
28. 26 not (9 or 20)
29. 9 or 20 or 28
30. exp headache/
31. exp physical therapy/












44. myofascial pain syndromes/th
45. traction.sh.
46. or/31-45
47. 30 and 46
48. 29 and 47
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W H A T ’ S N E W
Last assessed as up-to-date: 14 November 2002.
Date Event Description
29 August 2008 Amended Converted to new review format.
H I S T O R Y
Protocol first published: Issue 1, 2000
Review first published: Issue 3, 2004
D E C L A R A T I O N S O F I N T E R E S T
Two authors, Gert Bronfort and Nils Nilsson, are also authors of studies included in this review (Boline 1995; Bove 1998;Nilsson
1997).
S O U R C E S O F S U P P O R T
Internal sources
• Northwestern Health Sciences University, USA.
• Western States Chiropractic College, USA.
External sources
• University of Southern Denmark, Denmark.
• European Chiropractic Union, Switzerland.
• World Federation of Chiropractic (WFC), Canada.
• International Headache Society (for administrative costs associated with editorial review and peer review), Not specified.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Exercise Movement Techniques; ∗Physical Therapy Modalities; Chronic Disease; Headache [∗therapy]; Headache Disorders [∗therapy];
Recurrence
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MeSH check words
Humans
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